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African rhinoceros have economic and ecological value, yet they are threatened by 
poaching and habitat loss, which causes reduction in population numbers. In addition, infection 
with Mycobacterium bovis (M. bovis), a causative agent of bovine tuberculosis (bTB), may be a 
threat to their conservation. This legislatively notifiable infectious disease has serious 
consequences on management of African rhinoceros by restricting their movements; therefore, it 
is imperative to have accurate and easily available diagnostic tools for the detection of M. bovis 
infection, to ensure that infected rhinoceros are not translocated. In order to address this need, 
this study aimed to (i) optimize enzyme-linked immunosorbent assay (ELISA) conditions for 
detecting rhinoceros interferon-gamma (IFN-γ), (ii) develop a diagnostic antigen-specific IFN-γ 
release assay (IGRA) for rhinoceros, (iii) identify cytokine gene signatures that distinguish 
between M. bovis-infected and uninfected rhinoceros, and (iv) identify cytokines other than IFN-
γ with diagnostic potential to distinguish between M. bovis-infected and uninfected animals. 
Whole blood samples were collected from M. bovis-infected rhinoceros and uninfected 
animals from the Kruger National Park and incubated overnight at 37°C in tubes of the 
QuantiFERON (QFT) system. Thereafter, harvested plasma samples and cell pellets preserved in 
RNAlater, were stored at -80°C. Archived plasma was used to validate the equine Mabtech IFN-
γ ELISAPRO and then develop a diagnostic IGRA for rhinoceros. Using archived blood pellets, 
RNA was extracted, reverse transcribed, and screened using the equine RT2 profiler PCR array to 
identify candidate cytokine biomarkers. In addition, the Raybio® equine interferon gamma 
induced protein (IP-10) ELISA was used with rhinoceros plasma from QFT stimulated blood to 




The commercial Mabtech Equine IFN-γ ELISAPRO kit was validated as a robust and 
highly reproducible assay for the detection of rhinoceros IFN-γ. Thereafter, the QFT IGRA was 
shown to distinguish between M. bovis-infected and uninfected animals. The optimal cut-off 
value was calculated as 21 pg/ml, although test results ranging between 22–61 pg/ml were 
interpreted as indeterminate, and a test result of > 62 pg/ml as definitively positive. Using RNA 
extracted from QFT-stimulated rhinoceros whole blood, the equine RT2 profiler PCR array 
identified six potential cytokine gene targets. Further development of a gene expression assay for 
CXCL10 (IP-10) confirmed this cytokine as a promising biomarker based on significant 
upregulation in antigen-stimulated blood from M. bovis-infected rhinoceros. Based on this result, 
an equine IP-10 release assay (IPRA) was developed to demonstrate that antigen-specific IP-10 
could discriminate between M. bovis-infected and uninfected white rhinoceros. Additionally, the 
IPRA was able to detect one additional truly infected animal when used in parallel with the 
IGRA, suggesting that this may have potential as an additional diagnostic biomarker in 
rhinoceros. 
In summary, the novel tools developed in this project can be used to detect M. bovis 
infection in rhinoceros. Similar to other species, QFT IGRA and potentially IPRA may support 
testing of individual rhinoceros prior to translocation, as well as allow for disease surveillance. 
Future research should focus on additional biomarker discovery and understanding the 







Ten spyte van die groot ekonomiese en ekologiese waarde van Afrika-renosters, word 
hulle bedreig deur stroping en habitatverlies wat lei tot vermindering in die populasie se getalle. 
Daarby is infeksie met Mycobacterium bovis (M. bovis), die oorsaak van beestuberkulose (bTB), 
‘n bedreiging vir hul bewaring. Hierdie wetlike aanmeldbare aansteeklike siekte het ernstige 
gevolge vir die bestuur van Afrika-renosters deur die beperking van hul beweging; gevolglik is 
akkurate and maklik verkrygbare diagnostiese toetse vir die identifisering van M. bovis infeksie 
noodsaaklik om te verseker dat geinfekteerde renosters nie geskuif word nie. Om hierdie 
behoefte aan te spreek het hierdie studie gepoog om i) ELISA kondisies te optimiseer vir 
identifisering van renoster interferon-gamma (IFN- γ), ii) ‘n diagnostiese antigeen-spesifieke 
IFN- γ vrystellingstoets (IGRA) vir renosters te ontwikkel, iii) sitokine geen paneel te 
identifiseer wat kan onderskei tussen M. bovis-geinfekteerde en ongeinfekteerde renosters, en iv) 
identifisering van ander sitokienes as IFN- γ wat diagnostiese potensiaal het om te kan onderskei 
tussen M. bovis-geinfekteerde en ongeinfekteerde diere. Heelbloed monsters van M. bovis-
geinfekteerde en ongeinfekteerde renosters van die Kruger Nasionale Park is geneem en oornag 
geinkubeer by 37°C in buise van die QuantiFERON (QFT) sisteem. Daarna is plasma monsters 
geoes en sel klonte is gepreserveer en gestoor in RNAlater by -80°C.  
Gestoorde plasma monsters is gebruik om die Equine Mabtech IFN- γ ELISAPRO te toets 
en te ontwikkel vir 'n diagnostiese IGRA vir renosters. RNA is ge-ekstraëer vanaf gestoorde 
bloed, omgekeerd getranskribeer en gesif deur die perde RT2 profiel PKR opstelling om 
kandidaat sitokine as biomerkers te identifiseer. Daarby is die Raybio® perde interferon gamma 




gestimuleerde bloed van renosters om IP-10 van hierdie diere te identifiseer. Die kommersiele 
Mabtech perde IFN-γ ELISAPRO toets is beproef as ‘n geharde en herhaalbare toets vir die 
identifisering van renoster IFN-γ. Daarna is die QFT IGRA gebruik om te onderskei tussen 
M.bovis-infekteerde en ongeinfekteerde diere. Die optimale afsny waarde is bereken as 21 pg/ml, 
toets resultate tussen 22 – 61 pg/ml is geinterpreteer as intermediêr en ‘n toets resultaat van > 62 
pg/ml is beskou as positief. Die perde RT2 profiel PKR opstelling het ses potensiële sitokien 
gene in die RNA wat geekstraëer is van QFT-gestimuleerde renoster heelbloed monsters 
geidentifiseer. Die ontwikkeling van ‘n geen uitdrukking toets vir CXCL10 bevestig dat hierdie 
sitokien ‘n belowende biomerker is op grond van beduidende opregulering in antigeen-
gestimuleerde bloed van M. bovis-geinfekteerde renosters. Gebasseer op hierdie resultaat is ‘n 
perde IP-10 vrystellings toets (IPRA) ontwikkel wat gedemonstreer het dat antigeen-spesifieke 
IP-10 kon diskrimineer tussen M. bovis-geinfekteerde en ongeinfekteerde wit renosters. Daarby 
kon die IPRA een waarlik geinfekteerde dier identifiseer wanneer dit in parallel gebruik is met 
die IGRA. Dit stel voor dat hierdie toets die potensiaal het om as ‘n addisionele biomerker vir 
renosters te dien.  
Ter opsomming, in hierdie studie is nuwe tegnologie ontwikkel wat gebruik kan word om 
M. bovis infeksie in renosters te identifiseer. Soortgelyk aan ander spesies, kan die QFT IGRA en 
potensiëel ook IPRA die toetsing van individuele renosters ondersteun voor oorplasing/vervoer, 
asook vir siekte voorkoming. Toekomstige navorsing moet fokus op addisionele biomerker 
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This introductory chapter aims to provide a literature summary of the hosts, pathogen, 
and the diagnosis of Mycobacterium bovis (M. bovis) infection. Furthermore, it will highlight the 
justification for developing novel diagnostic tools to detect M. bovis infection in African 
rhinoceros, as well as setting the research questions and study aims, and describing the 















Black (Diceros bicornis) and white (Ceratotherium simum) rhinoceros  
Rhinoceros species belong to a taxonomic order known as perissodactyla (odd-toed 
ungulate) (Murphy et al., 2001; Steiner and Ryder, 2011). The two extant African rhinoceros 
species, black and white rhinoceros, reside in sub-Saharan Africa (Standley and Emslie, 2013). 
According to the International Union for Conservation of Nature Red List (IUCN; 
http://www.iucnredlist.org/), the black rhinoceros is classified as ‘critically endangered’ while 
the white rhinoceros is ‘near threatened’. In Africa, black rhinoceros populations are in decline, 
and white rhinoceros are following suit due to poaching for their horns and habitat loss (Standley 
and Emslie, 2013).  
Rhinoceros are the second largest herbivores after the elephant and play an influential 
role in consuming large amounts of vegetation, which helps shape the African landscape. This 
benefits other animals and maintains ecosystem balance which may be disturbed if their numbers 
are affected (Waldram et al., 2008; Ripple et al., 2015). Additionally, they are also considered as 
ecosystem engineers by creating biological barriers when grass is grazed short, potentially 
altering the size, frequency, and distribution of fires in the landscape (Jones et al., 1994). 
Furthermore, rhinoceros species are iconic with tangible economic benefits through tourism at 
zoos and nature reserves, and wildlife ranching (Taylor et al., 2016). In order to promote 
conservation of natural resources and endangered wildlife, rhinoceros are translocated nationally 
and internationally as part of a sustainable utilization strategy (Taylor et al., 2016). While the 
illegal hunting of rhinoceros continues to impact their chances of survival, their susceptibility to 
infectious diseases such as bovine tuberculosis (bTB) may be an additional threat to their 







Tuberculosis (TB) may result from infection by bacteria belonging to the Mycobacterium 
tuberculosis complex (MTBC), a group of closely related multi-host pathogens of public health 
and veterinary importance, including Mycobacterium tuberculosis (M. tb) and M. bovis 
(Alexander et al., 2010). Members of the MTBC are slow growing, acid-fast bacilli (Ashford et 
al., 2001).  
Bovine tuberculosis is a disease, caused by M. bovis infection, with a wide host range, 
which includes both captive and free-ranging wildlife (Morris et al., 1994; Alexander et al., 
2002; Katale et al., 2017). Wildlife populations known to be endemically infected, including the 
African buffalo (Syncerus caffer) in South Africa, badger (Meles meles) in the United Kingdom, 
brushtail possum (Trichosurus vulpecula) in New Zealand, act as maintenance hosts, and allow 
transmission among individuals, as well as spill-over to other species (Alexander et al., 2002; 
Renwick et al., 2006). 
 Transmission of M. bovis occurs via different routes, depending on host species and 
infection burden in the population. Inhalation of M. bovis aerosols are the common route of 
transmission when there is prolonged contact between infected and healthy domestic, wild 
animals, or humans (Ashford et al., 2001; Michel et al., 2009). Close contact between animals 
usually occurs, for example, at points such as water sources and feeding sites (Renwick et al., 
2007). In hot weather, animals tend to congregate under trees for parts of the day, or share 
wallows (Renwick et al., 2007). It has been demonstrated that infectious animals may shed M. 
bovis in several ways, through faeces, discharging lesions, urine, and saliva (Neill et al., 1991). 




contaminated material such as milk, pasture, or water (Ayele et al., 2004). Furthermore, 
consumption of infected tissues by a susceptible animal can result in transmission from prey to 
predators, especially carnivores (Renwick et al., 2007). Irrespective of the precise route of M. 
bovis spread, the period from infection to progression of chronic disease can last months to 
years, and leads to granulomatous inflammation in the lungs, lymph nodes and other organs 
(Keet et al., 2000; Ashford et al., 2001; Michel et al., 2010).  
Impacts of TB in domestic livestock and wildlife include mortality, zoonotic 
transmission, loss in production, spread to other species, and potential for maintenance in the 
ecosystem (Michel, 2002). Furthermore, in South Africa, premises with infected animals are 
placed under veterinary quarantine with movement restrictions which affects livestock 
production system (Arnot and Michel, 2020) and wildlife conservation (pers. comm. Dr Peter 
Buss, 2016). 
Bovine tuberculosis in South African wildlife 
Bovine tuberculosis was introduced into South Africa during the colonial era, with 
immigration of European settlers and their livestock (Smith et al., 2011). This was confirmed by 
isolation of European 1 clonal complex of M. bovis in South Africa in cattle in 1880 (Renwick et 
al., 2007; Michel et al., 2008). Bovine TB was first recognized in Hluhluwe-iMfolozi Park (HiP) 
in 1986 and the Kruger National Park (KNP) in 1990 when M. bovis was isolated from buffaloes 
(Bengis et al., 2000). Since that time, African buffaloes, and greater kudu (Tragelaphus 
strepsiceros) have become maintenance hosts for bTB in South Africa (de Vos et al., 2001; 
Rodwell et al., 2001). Both KNP and HiP are considered endemic areas for M. bovis and there is 
an increasing number of African wildlife species reported with bTB (Keet, 2000; Michel, 2012). 




1996; Bengis et al., 2001; Michel et al., 2006; Buss, 2015; Olivier et al., 2015; Miller et al., 
2017a; Miller et al., 2018; Roos et al., 2019; Higgitt et al., 2017; Higgitt et al., 2019; Hlokwe et 
al., 2019; Miller et al., 2019; Kerr et al., 2020). However, not all species are equally affected, but 
are often grouped as either spill-over (dead-end) hosts or maintenance hosts (Ayele et al., 2004). 
In South Africa, cattle and African buffaloes are considered the primary and most well-known 
reservoirs or maintenance hosts. Therefore, transmission of M. bovis infection from these 
maintenance hosts to other wildlife species or livestock is inevitable if not controlled, as well as 
potential spill-back (de Garine-Wichatitsky et al., 2013).  
 A bTB test-and-slaughter control strategy was implemented in South Africa in 1969 for 
cattle, which led to decreased prevalence (Hlokwe et al., 2014); however, lack of testing 
programs for communal livestock and paucity of diagnostic tests for wildlife species has allowed 
persistence of bTB in these populations (Michel et al., 2006). The interface between wildlife and 
livestock, especially in communities bordering bTB endemic parks, provides an opportunity for 
ongoing spread of M. bovis (Hlokwe et al., 2014). Spill-over and spill-back events between 
species continue to pose a significant risk unless bTB can be controlled within the wildlife 
maintenance hosts. Similar scenarios have been reported from Spain where a link was found 
between reinfection of livestock and infected badgers (Acevedo et al., 2019). In addition, the 
absence of bTB control in cattle results in potential ongoing spill-over to wildlife (Arnot et al., 
2020). In order to manage and control bTB in South Africa, there is a need to understand the 
epidemiology of bTB in multi-host systems, which requires the development of tools to identify 






Tuberculosis in rhinoceros 
Tuberculosis has been reported in different rhinoceros species around the world. 
Infections with M. tb and M. bovis have resulted in morbidity and mortality in captive rhinoceros 
species (Mann, 1981; Barbiers, 1994; Stetter et al., 1995; Valandikar and Raju, 1996; Espie et 
al., 2009). Many of the historical M. tb cases have occurred in captive black rhinoceros, with 
only a few cases in white rhinoceros (Miller et al., 2016). This may be due to differences in 
housing or management of these species in zoological collections, or other risk factors such as 
their level of exposure to infected animals or people (Miller et al., 2016). Since the TB cases in 
zoo rhinoceros resulted in pulmonary disease, it is speculated that the route of transmission was 
through aerosolized mycobacteria (Oh et al., 2002). 
In contrast, fewer cases of M. bovis infections are reported in rhinoceros. In South Africa, 
a case of mycobacteriosis was identified in a black rhinoceros in 1956 (Hofmeyr, 1956), and in 
another case in 1970, a black rhinoceros in HiP, which were presumptively diagnosed based on 
lesions consistent with TB (Keep and Basson, 1973). The first M. bovis culture-confirmed case 
occurred in a geriatric semi-captive black rhinoceros that had localised lesions (Espie et al., 
2009). Yet it was only in 2016 that the first case of M. bovis was confirmed in a free-ranging 
black rhinoceros in KNP, followed by additional cases in white rhinoceros (Miller et al., 2017; 
Miller et al., 2018). 
The route of M. bovis transmission in rhinoceros is unknown, however, ingestion of M. 
bovis through consumption of contaminated vegetation could be another route in grazing and 
browsing species (Ayele et al., 2004; Rewick et al., 2007). In South Africa, rhinoceros share 
range and resources with buffalo and greater kudu populations, which are important maintenance 




findings in infected rhinoceros are granulomatous lesions, primarily in lungs and lymph nodes 
(Song, 2001; Espie et al., 2009; Miller et al., 2016). This may be due to the overlap in 
grazing/browsing and water sources, frequented by rhinoceroses, buffaloes and greater kudus, 
could pose a threat for potential disease transmission (Michel et al., 2017), suggestive that 
infection may spread through aerosol transmission. However, irrespective of the exact route of 
infection, it may take years for clinical signs to develop (Keet et al., 2000).  
Clinical signs of TB are generally related to the route of infection and target organs involved, 
although reports in rhinoceros are limited to those few cases that have been described in the 
literature. Clinical signs that have been associated with progressive TB include coughing, 
sneezing, nasal discharge, respiratory discharge, fever, lethargy, decreased appetite, weight loss, 
and anemia (Valandikar and Raju, 1996; Song, 2001; Espie et al., 2009; Miller et al., 2015; 
Miller et al., 2017a). Since KNP is endemic for M. bovis and home to large African rhinoceros 
populations, the finding of bTB in rhinoceros emphasizes the importance of developing sensitive, 
specific and accurate diagnostic tools to better understand the pathogenesis, transmission of M. 
bovis infection, and its impact on African free-ranging rhinoceros populations.  
The immunology of tuberculosis 
Generally, cell-mediated immunity (CMI) plays an important role in the control of TB 
(Orme and Cooper, 1999). As part of anti-mycobacterial immunity, there is development of a T 
helper type 1 (Th1) CMI response, along with the production of cytokines. Among the key 
cytokines, interleukin (IL)-12, interferon gamma (IFN-γ), and tumour necrosis factor alpha 
(TNF-α) are important in activating macrophage microbiocidal pathways (Orme and Cooper, 




CD8+ T-cells, and natural killer (NK) cells. It acts on B cells, T cells, NK cells, and macrophages 
(Vivier et al., 2008) to promote protection against mycobacterial infection (Cooper et al., 1993).  
The T helper type 2 (Th2-type) cytokines (e.g. IL-3, IL-4, IL-5, IL-13) are involved in promoting 
antibody-mediated responses (Whiteside, 2002). Previous studies have suggested a shift in 
predominance from CMI to humoral responses occurs as infection progresses (Ritacco et al., 
1991; Boussiotis et al., 2000; Dlugovitzky et al., 2000; Pollock et al., 2001; Welsh et al., 2005). 
Therefore, measurement of these different antigen-specific responses may provide indirect 
methods of diagnosing infection and disease. 
Diagnosis of bovine tuberculosis 
Bovine tuberculosis is diagnosed by either detecting the M. bovis organism or DNA 
(direct tests) or host immune responses to mycobacterial antigens (indirect tests). Direct 
diagnostic assays include identification of acid-fast bacilli in clinical samples, or mycobacterial 
culture and speciation by polymerase chain reaction (PCR) (Maas et al., 2013). Microscopic 
examination using acid-fast staining of respiratory secretions or tissues is a simple, inexpensive 
method and can provide a presumptive diagnosis (Uddin et al., 2013). However, this technique is 
non-specific and highly insensitive with less than 60% sensitivity under optimal conditions 
compared to culture (Apers et al., 2003). Mycobacterial culture isolation is still considered the 
“gold standard” for bTB diagnosis, however, the long processing time is a major limitation of 
this method (Almeida and Araujo, 2013). Due to the characteristic slow growth of mycobacteria 
in culture, the BACTEC™ MGIT™ (Becton Dickinson, Franklin Lakes, NJ, USA) was 
developed as an improved culture tool which provides faster and more accurate results than 
traditional solid culture methods (Robbe-Austerman et al., 2013). This automated mycobacterial 




samples as well as ante-mortem bronchoalveolar lavage, trunk wash fluid and oropharyngeal 
swab samples from African wildlife (Miller et al., 2015; Bernitz et al., 2018; Miller et al., 2018; 
Roos et al., 2018; Higgitt et al., 2019). Molecular techniques, such as PCR, play an important 
role in identifying and differentiating M. bovis isolates from the other members of the MTBC 
that have been cultured or observed directly in samples (Ayele et al., 2004; Goosen et al., 2020). 
One of the most commonly used techniques is based on presence and absence of Regions of 
Difference (RD) in MTBC using PCR (Warren et al., 2006). In addition, a recent study 
demonstrated the use of the VetMAX MTBC PCR kit (ThermoFisher Scientific, MA, USA) as a 
new tool for the detection of M. bovis in various sample types from African wildlife species 
(Goosen et al., 2020). Furthermore, genotyping techniques to further identify strains, such as 
variable-number tandem repeat typing (VNTR), restriction fragment length polymorphism 
(RFLP) typing, spoligotyping, next generation sequencing (NGS) and whole genome sequences 
(WGS), provide additional data useful for disease epidemiologic investigations and identifying 
potential sources of M. bovis (Hlokwe et al., 2014; Musoke et al., 2015; Dippenaar et al., 2017).  
Indirect detection of M. bovis depends on the development of bTB-specific immune 
responses. Cell-mediated immune responses develop soon after infection, after which, as the 
disease progresses, the humoral response is activated, and antibody titres increase (Pollock and 
Neill, 2002). Factors such as host species, immunological competence, initial infection dose, and 
stage of disease determine the presence and magnitude of CMI and humoral responses (Buddle et 
al., 2013). The tuberculin skin test (TST), which is an indirect in vivo detection method, has been 
a standard diagnostic test for bTB worldwide. The TST measures the delayed hypersensitivity 
response induced by purified protein derivatives (PPD) from M. bovis (and M. avium) injected 




diagnostic test in others (including rhinoceros), although it has been rarely validated and 
standardized for these species (Godfrey et al., 1990; Keet et al., 2010). Disadvantages of TST 
when applied in free-ranging wildlife include unknown standards for tuberculin doses and 
measurement interpretation, the requirement for recapture after three days to read the test 
(Chambers et al., 2009; Chambers, 2013), and influence of exposure to environmental 
mycobacteria on background responses (van Helden et al., 2008). Therefore, blood-based assays 
have been developed to avoid these limitations.  
The IFN-γ release assay (IGRA) is an in vitro assay based on stimulation of whole blood 
or peripheral blood mononuclear cells (PBMC) with M. bovis antigens. Immune sensitization is 
detected by measuring release of antigen-specific IFN-γ by sandwich ELISA or enzyme-linked 
immunospot (ELISPOT) (Wood et al., 1990). These assays were initially developed with PPDs 
as antigens but had compromised specificity due to antigenic cross-reactivity (Lightbody et al., 
1998). For cattle, the specificity was improved using more defined antigens (MPB83 and 
MPB70) (Buddle et al., 2001). The QuantiFERON-TB Gold In-Tube (QFT) (Qiagen, Venlo, 
Netherlands) system was developed for human IGRA and employs a peptide cocktail simulating 
the antigens early secreted antigenic target 6 kDa protein (ESAT-6) and culture filtrate protein 10 
(CFP-10) (Theel et al., 2018). The use of the QFT blood collection tubes, in combination with an 
appropriate IFN-γ ELISA, has been advocated for field testing of African wildlife because it is 
easy to use, provides high diagnostic specificity, and can be adapted for use in multiple wildlife 
species (Parsons et al., 2011). Additionally, IGRAs remain the most widely used and 
recommended immunological tests for M. tb diagnosis in humans (Pai et al., 2014) and M. bovis 
in cattle (Bezos et al., 2014; Parsons et al., 2016; Palmer et al., 2020), and in some wildlife 




dogs (Lycaon pictus) (Higgitt et al., 2019). However, studies have demonstrated that IGRAs may 
be suboptimal for diagnosis in bovids (Vordermeier et al., 2000; Bernitz et al., 2020) and results 
in false negatives in advanced TB cases in humans (Pai et al., 2005; 2014). Therefore, 
identification of alternative or ancillary biomarkers of bTB infection to IFN-γ is necessary to 
increase the sensitivity of M. bovis-specific assays (Waters et al., 2003; Blanco et al., 2011; 
Bernitz et al., 2019). Several host biomarkers of CMI responses have emerged as potential 
candidates for use in either gene expression or protein blood-based assays in humans (Walzl et 
al., 2011; Chegou et al., 2018) and animal species, including interleukin-1β (IL-1β) (Jones et al., 
2010; Elnaggar et al., 2017), interleukin-2 (IL-2) (Rhodes et al., 2014), chemokine C-X-C motif 
ligand 9 (CXCL9) also known as monokine induced by IFN-γ (MIG) (Olivier et al., 2017; Kerr 
et al., 2020), chemokine C-X-C motif ligand 10 (CXCL10) also known as IFN-γ-induced 
protein-10 (IP-10) (Waters et al., 2012; Bernitz et al., 2019; Palmer et al., 2020), tumour necrosis 
factor-alpha (TNF-α), nitric oxide (NO) (Durbach et al., 2003), interleukin-17 (IL-17) (Blanco et 
al., 2011), and interleukin-22 (IL-22) (Steinbach et al., 2016).  
Serological tests are also used as indirect diagnostic assays for detection of host antibody 
responses to mycobacterial antigens (Wood et al., 1992). There are a variety of antibody 
detection assays, including the indirect ELISA (Parsons et al., 2017; Roos et al., 2016), 
fluorescence polarization assay (FPA) (Jolley et al., 2007), lateral flow chromatography such as 
the STAT-PAK assay (Miller et al., 2015; Kerr et al., 2019; Miller et al., 2019), dual-path 
platform (DPP) technology (Roos et al., 2016; Kerr et al., 2019; Miller et al., 2019), and blotting 
methods like the multi-antigen print immunoassay (MAPIA) (Waters et al., 2011). Serodiagnosis 
has been useful as a screening tool for detecting M. bovis infection in some domestic and wildlife 




al., 2017), warthogs (Roos et al., 2016), wild boar (Aurtenetxe et al., 2008), rhinoceros (Duncan 
et al., 2009), and elephants (Kerr et al., 2019; Miller et al., 2019). However, antibody production 
changes significantly during infection and is typically produced in advanced stages of infection 
(Pollock and Neill, 2002). Thus, tests based on humoral responses are generally not as sensitive 
as those based on the CMI response in many species, specifically during early stages of infection 
(Wood et al., 1992; Lightbody et al., 1998; Wiker et al., 1998; McNair et al., 2001). However, 
early antibody responses have been reported in some animal species such as experimentally 
infected cattle (Waters et al., 2006), naturally infected wild suids (Boadella et al., 2011; Roos et 
al., 2016), and elephants (Lyashchenko et al., 2006; Greenwald et al., 2009). Therefore, 
diagnostic tests need to be tailored for each species, based on knowledge of the patterns of 
specific host responses.  
The development of improved and accurate diagnostic immunoassay tests for bTB also 
requires knowledge of the factors which impact host responses. Factors which influence test 
performance and selection of tests include the stage of infection, occurrence of disease, and 
species-specific inconsistency in immune responses (De La Rua-Domenech et al., 2006). It is 
therefore necessary to understand specific immune responses to bTB in each wildlife species. 
Diagnostic tests for mycobacterial infection in African rhinoceros 
Since clinical signs are vague and may only be noticed in advanced disease, a diagnostic 
tool to detect early infection is needed for rhinoceroses. Of the diagnostic methods available to 
diagnose TB in animals, mycobacterial culture has been the most used method to diagnose 
infection in rhinoceros (Espie et al., 2009; Miller et al., 2017a). Samples for culture are typically 
only obtained at post-mortem examination, although techniques for obtaining culture samples 




swabs (Espie et al., 2009; Goosen et al., 2020; Hermes et al., 2018; Michel et al., 2017; Stetter et 
al., 1995). However, these sample types are only useful in animals that are shedding, resulting in 
a test that has low sensitivity (Michel et al. 2017; Miller et al., 2015). Furthermore, results from a 
recent study of three white rhinoceros experimentally infected with a virulent M. bovis showed 
no evidence of clinical disease, but the presence of minor and small tuberculosis lesions in the 
lung post mortem suggests a risk of inactive tuberculosis (Michel et al., 2017). Regardless of the 
low incidence of tuberculosis in free ranging rhinoceros, the possible intra and inter species 
transmission of M. bovis or in a captive setting demands for diagnostic tests (Lécu and Ball, 
2011). 
Diagnostic tests for TB based on host responses in rhinoceros are limited. The use of TST 
in species such as rhinoceroses, has not been standardized and has a high chance of false positive 
test results due to exposure to environmental mycobacteria (Godfrey et al., 1990; Espie et al., 
2009). Therefore, the presence of serum antibodies to M. bovis and M. tb, using ELISA, multi-
antigen print immunoassay (MAPIA) and ElephantTB STAT-PAK® have previously been used 
in black and white rhinoceros for diagnosis (Duncan et al., 2009; Miller et al., 2017a; Parsons et 
al., 2017). These assays allow retrospective analyses as well as show potential value for 
monitoring response to treatment of TB in rhinoceros. For example, serum antibodies have been 
shown to gradually decline when infected rhinoceros were treated with anti-tubercular 
therapeutics (Miller et al., 2017a). 
Since serological assays may not detect early infection in rhinoceros, blood-based CMI 
assays have been investigated. To develop cytokine assays, the white rhinoceros IFN-γ gene has 
been cloned and sequenced (Morar et al., 2007). Antibodies were successfully produced to the 




antibodies to detect IFN-γ in plasma from mitogen-stimulated rhinoceros whole blood (Morar et 
al., 2007; Morar et al., 2015). Although, this rhinoceros-specific IFN-γ ELISA was able to detect 
IFN-γ in plasma, the assay was not validated for antigen-specific responses. Recently, the QFT 
blood stimulation platform, in combination with an in-house ELISA using commercial bovine 
IFN-γ antibodies, has been able to detect antigen-specific IFN-γ production in M. bovis-infected 
black and white rhinoceros (Miller et al., 2017a; Miller et al., 2018). In addition, results from an 
experimental M. bovis infection study of three white rhinoceroses support the use of the QFT 
bovine IFN-γ ELISA compared to rhinoceros-specific IFN-γ release assay for detection of 
immune responses in this species (Parsons et al., 2017). Additionally, the experimental M. bovis 
infection study of white rhinoceroses characterised antigen-specific immune response patterns to 
M. bovis infection for a duration of 20 months and all three rhinoceros reflected an effective 
control of M. bovis infection, suggesting the usefulness of IFN-γ to detect infection (Parsons et 
al., 2017). However, further studies investigating immune response patterns in naturally infected 
rhinoceros are required. 
There is a lack of tests for diagnosing bTB in free-ranging wildlife species including 
African rhinoceros, which limits our understanding of the role and management of the disease in 
these species. Ante-mortem techniques are especially important for wildlife species which are 
indigenous, protected, individually valuable, and when post-mortem samples are unavailable (de 
Lisle et al., 2002; Morar et al., 2007). Therefore, further research is necessary to validate a QFT 
IFN-γ release assay (IGRA) and assess test performance in free-ranging African rhinoceros. 
Additionally, there is a need to identify and characterize other novel immunological cytokine 





Justification for study 
The discovery of M. bovis infection in a free-ranging black rhinoceros in KNP along with 
additional sporadic cases of bTB (in black and white rhinoceros) in South Africa, highlights the 
threat that this infectious disease may have in disrupting conservation programs by restricting 
translocations (Espie et al., 2009; Miller et al., 2017b; Miller et al., 2018). The Department of 
Agriculture, Land Reform, and Rural Development (DALRRD) has already imposed a 
quarantine that prohibits movement of rhinoceros from KNP, since the discovery of bTB cases in 
2016 (Dr. Peter Buss, pers. comm.). This has highlighted the large knowledge gaps regarding M. 
bovis transmission, susceptibility to infection, risk factors, progression to disease, prevalence in 
different rhinoceros species and populations, and impact on rhinoceros ecology and 
conservation. Understanding these aspects of bTB in rhinoceros requires reliable tools to 
diagnose individuals and screen populations. This study focuses on developing those tools. 
Study research questions and aims: 
1. What are the optimal ELISA conditions for detecting African rhinoceros IFN-γ? 
Aims: 
i) To select an optimal antibody pair to develop a rhinoceros IFN-γ ELISA. 
ii) To characterize and validate a rhinoceros IFN-γ ELISA. 
2. Can a diagnostic IGRA be developed to detect M. bovis infection in rhinoceros?  
Aims: 
i) To measure IFN-γ in QFT-stimulated whole blood from M. bovis-infected and 
uninfected rhinoceros using the validated IFN-γ ELISA. 





iii) To determine a diagnostic cut-off value and test performance of an optimized 
QFT IGRA for use in rhinoceros. 
3. Can cytokine gene expression assays be used to distinguish between M. bovis-infected 
and uninfected African rhinoceros? 
Aims: 
i) To screen cytokines and chemokines candidate genes for use as biomarkers of 
immune activation in rhinoceros QFT-stimulated whole blood. 
ii) To optimize rhinoceros-specific qPCR assays for selected chemokine genes.  
iii) To identify gene signatures to distinguish between M. bovis-infected and 
uninfected rhinoceros. 
4. Can release assays for cytokines other than IFN-γ be used to differentiate M. bovis-
infected and uninfected African rhinoceros? 
Aims: 
i) To detect selected cytokines (according to the outcomes of research question 3) in 
rhinoceros mitogen and antigen stimulated whole blood using selected ELISAs. 
ii) To optimize selected cytokine ELISAs. 
iii) To compare antigen-specific cytokine release in M. bovis-infected and uninfected 
rhinoceros to identify biomarkers with diagnostic potential. 
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Kruger National Park (KNP), South Africa, home to the largest population of white 
rhinoceros (Ceratotherium simum) in the world, where bovine tuberculosis (bTB) caused by 
Mycobacterium bovis (M. bovis) is endemic. In 2016, the first cases of naturally occurring bTB 
were reported in white rhinoceros; however, there is a lack of understanding of infection and 
disease process in this species. Prevention and control of transmission depends on the availability 
of accurate tools to detect M. bovis infection. Interferon gamma (IFN-γ) assays are a reliable 
diagnostic method for TB in other animal species, and studies have indicated that these tests can 
be used in white rhinoceros. In this study, we sought to screen and optimize commercially 
available IFN-γ enzyme linked immunosorbent assay (ELISA) systems to detect endogenous 
white rhinoceros IFN-γ in mitogen-stimulated whole blood as a basis for developing a diagnostic 
test for M. bovis infection. Optimizations included identifying ELISA antibodies, determining 
the effect of sample matrix, ELISA linearity, effects of ELISA plate incubation temperature, 
assay reproducibility, and the assay’s limit of quantification. The optimized assay employed an 
equine IFN-γ antibody pair that was used to create a commercially available ELISA kit. This 
ELISA showed a linear response to recombinant equine and endogenous rhinoceros IFN-γ 
(ranging from 7.8 to 125 pg/ml). When incubated at 37◦C, the ELISA was highly reproducible, 
with an optimal recovery and a low limit of quantification, indicating that the Mabtech Equine 









The white rhinoceros (Ceratotherium simum) is classified as “Near Threatened” by the 
International Union for Conservation of Nature and is under high poaching pressure in a number 
of African countries (Emslie, 2012; Miller et al., 2018). In South Africa, the majority of white 
rhinoceros are found in Kruger National Park (KNP), a bovine tuberculosis (bTB) endemic area 
rife with poaching. Even though Mycobacterium bovis infection has been reported in a wide 
range of wildlife, it was only in 2016 that the first cases were found in wild white rhinoceros 
(Miller et al., 2017). In order to understand M. bovis infection and disease processes, it is crucial 
to recognize the role of the host’s immunological response. An effective immune response 
against M. bovis is dependent on T helper type-1 (Th1) cell-mediated immunity (CMI) (de la 
Rua-Domenech et al., 2006). Interferon gamma (IFN-γ) is a key cytokine in this response and 
has been shown to be an important diagnostic biomarker for the diagnosis of mycobacterial 
infections in domestic cattle, wildlife and humans (de la Rua-Domenech et al., 2006; Gormley et 
al., 2006). However, immune responses are not well characterized in most wildlife species such 
as rhinoceros. Therefore, understanding the comparative immunobiology of M. bovis infection 
requires the development of assays to detect and measure immune responses (Maas et al., 2013).      
The white rhinoceros IFN-γ gene has been cloned and expressed, with the recombinant 
protein used for the production of rhinoceros IFN-γ specific antibodies (Morar et al., 2007). The 
inferred IFN-γ amino acid sequence was shown to have 90% homology to that of equines (Morar 
et al., 2007). Using rhinoceros-specific and commercial bovine IFN-γ antibodies in ELISAs, a 
previous study demonstrated that antigen-specific IFN-γ production is a promising 
immunological technique for the detection of M. bovis infection in white rhinoceros (Parsons et 




with equine IFN-γ and could detect endogenous white rhinoceros IFN-γ (Parsons et al., 2017). 
The findings in this study suggest that commercially available reagents may be utilized for 
developing immunoassays in wildlife (Parsons et al., 2017). Therefore, the aim of this study was 
to screen and optimize a commercially available IFN-γ ELISA system to detect and measure 
endogenous white rhinoceros IFN-γ in mitogen-stimulated whole blood. The optimized assay 
could then be further evaluated as a potential diagnostic test for M. bovis infection. 
Materials and Methods  
Animals  
Blood samples were collected opportunistically from immobilized white rhinoceros in 
KNP, South Africa, during routine management procedures or for other approved activities 
according to the standard operating procedures for the capture, transportation and maintenance in 
holding facilities of wildlife (South African National Parks). Ethical approval for this project was 
granted by the Stellenbosch University Animal Care and Use Committee (SU-0966), and a 
section 20 research permit was issued by the Department of Agriculture, Forestry and Fisheries 
(DAFF) (No. 12/11/1/7/2). 
Whole blood stimulation 
Rhinoceros whole blood was collected in sealed lithium heparin vacutainers (BD 
Biosciences, Franklin Lakes, NJ, USA) and for each animal, one ml aliquots were transferred to 
two empty serum vacutainer tubes with gas permeable caps. Pokeweed mitogen (PWM, Sigma-
Aldrich, St. Louis, MO, USA) in phosphate buffered saline, pH 7.4 (PBS, Thermo Fisher 
Scientific, Waltham, MA, USA) was added to one tube at a final assay concentration of 10 µg/ml 
and 10 µl sterile PBS to the other tube. The tubes were designated as PWM and Nil, respectively, 




microcentrifuge tubes and plasma was harvested following centrifugation at 2000 x g for five 
minutes. Plasma samples derived from mitogen-stimulated and unstimulated whole blood were 
screened using bovine antibodies as previously described (Parsons et al., 2017) and five samples 
with high IFN-γ concentrations (compared to nil concentrations for each animal) were selected 
and pooled to create a reference sample with sufficient volume for repeated ELISAs. Plasma 
samples were then stored at -80°C until analyzed. 
Screening of anti-IFN-γ antibodies 
Commercially available ELISA antibody pairs were selected as potential candidates for 
the detection of rhinoceros IFN-γ (Table 2.1). Capture antibodies were diluted to 2 µg/ml in 1x 
PBS (Thermo Fisher Scientific). A 96-well microtiter plate (Greiner Bio-one, Heidelberg, 
Germany) was coated by adding 100 μl/well of diluted capture antibody and incubating the plate 
overnight at 4°C. The plate was washed four times (300 µl/well) with wash buffer solution (PBS 
with 0.05% Tween 20; Sigma Aldrich). Thereafter, 200 μl blocking buffer (BB, wash solution 
with 0.1% bovine serum albumin; Roche, Basel, Switzerland), was added to each well and the 
plate incubated at room temperature (RT, 19°C on the day of analysis) for one hour. After 
washing the plate four times, the pooled PWM plasma was diluted 1:2 in BB and 100 µl added to 
each well in duplicate. The plate was covered, incubated at RT for two hours then washed four 
times. Detection antibodies were diluted to 1 µg/ml in BB, 100 µl added to each well and 
incubated at RT for one hour. Following incubation, the plate was washed four times and 100 
μl/well of streptavidin-horseradish peroxidase (HRP, R&D Systems, Minneapolis, MN, USA), 
diluted 1:200 in BB, was added and incubated at RT for one hour. The plate was washed as 
above and 100 μl of colorimetric 3,3',5,5'-tetramethylbenzidine (TMB) enzyme substrate (BD 




reaction was stopped by adding 100 μl of 2M H2SO4 solution to each well. The optical density 
(OD) of each test and control well was measured at 450 nm and 630 nm as reference wavelength, 
using a VersaMax™ ELISA Microplate reader with SoftMax® Pro Software (Molecular Devices, 
San Jose, CA, USA). The ELISA results were calculated as the OD value measured at 630 nm 
subtracted from that measured at 450 nm; negative assay controls were used to ensure that the 
test well signal was specific to the PWM plasma sample and normalize OD values. Those 




















Table 2.1 Commercial interferon gamma (IFN-γ) enzyme linked immunosorbent assay kits and 
development kits screened for the detection of endogenous rhinoceros IFN-γ. 
Analyte Antibody Type Plasma dilution Manufacturer Product Information  
Development ELISAs 
Bovine IFN-γ MT17.1a, MT30b  1:2 Mabtech Ab, Nacka 
Strand, Sweden 
3119-1H-20 
Bovine IFN- γ bIFN-γ-1a, PAN-biotin 
b 
 1:2 Mabtech  3115-1H-20 
Canine IFN-γ MT13a, MT166-biotinb  1:2 Mabtech  3113-1H-6 
Equine IFN-γ MT166a, MT13-biotinb  1:2 Mabtech  3117-1H-6 (Batch 11) 
Ferret IFN-γ MTF14a, MTF19-
biotinb 
 1:2 Mabtech  3112-1H-6 
Porcine IFN-γ pIFN-γ-1 a, p2CII b  1:2 Mabtech  3130-1H-20 
Precoated ELISA kits 
Equine IFN-γ   N/A  1:2 Sigma-Aldrich, St. 
Louis, MO, USA  
RAB0583-1KT 
Equine IFN-γ  N/A  1:2 RayBiotech, Peachtree 




 N/A  Undiluted  MyBioSource, San 
Diego, CA, USA 
ELE-IFNg  





Selection of an IFN-γ ELISA 
The pooled PWM rhinoceros plasma was diluted 1:8 in BB and assayed in duplicate 
using the Mabtech bovine IFN-γ Ab pair (kit 3115) and Mabtech equine IFN-γ Ab pair (kit 3117) 
as described above. Furthermore, these samples were assayed using three IFN-γ ELISA kits that 
included pre-coated plates and supplied reagents according to their manufacturer’s instructions 
(Table 2.1). The ELISA displaying the greatest mean OD result for duplicate test wells was 
selected for further validation. 
Validation of IFN-γ ELISA 
A customized pre-coated equine IFN-γ ELISAPRO kit (Mabtech, catalog number: 3117-
1HP-10) utilizing the selected equine anti-IFN-γ antibody pair was used according to the 
manufacturer’s instructions, except for the incubation temperature, as described below. A10 µl 
aliquot of recombinant equine IFN-γ (rIFN-γ) standard solution (500 000 pg/ml) was diluted in 5 
ml sample diluent buffer (provided in the kit) to create a working solution of 1000 pg/ml. This 
was serially diluted 1:2 (2-fold dilutions) to produce a dilution series ranging from 1000 pg/ml to 
7.8 pg/ml. The ELISA results were measured and calculated as above; the relationship between 
OD and IFN-γ concentration was described using linear regression analysis using a standard 
curve to determine rhinoceros IFN-γ concentrations, as previously described (Cox et al., 2012), 
using GraphPad Software, version 5 (GraphPad Software, March 2007, San Diego, CA, USA). 
To characterize the assay performance at various incubation temperatures, the rIFN-γ 
dilution series described above was assayed in duplicate, with all incubations performed at either 
RT, 30°C or 37°C, except for the TMB substrate step, which was performed in the dark at RT. 
Results for each ELISA were analyzed by regression analysis as described above. Hereafter, all 




To determine the recovery of rIFN-γ in a rhinoceros plasma matrix, Nil plasma was 
utilized from three randomly selected rhinoceros. The concentrations of IFN-γ in the rhinoceros 
Nil samples were measured using the equine IFN-γ ELISAPRO kit. For each animal, rIFN-γ was 
spiked into a reference sample consisting of 100% sample diluent, and two test samples, 
consisting of 50% plasma (1:2 dilution in sample diluent) and 25% plasma (1:4 dilution in 
sample diluent), respectively. Concentrations of rIFN-γ in each sample were calculated with 
reference to a standard curve as described above. The recovery (%) of spiked rIFN-γ in the test 
samples was calculated as: ([rIFN-γ] in test sample ÷ [rIFN-γ] in reference sample) x 100. 
Assay linearity and parallelism were evaluated for IFN-γ ranging in concentration from 
7.8 to 125 pg/ml. Pooled PWM plasma was diluted in sample diluent to obtain a plasma sample 
with approximately 125 pg/ml endogenous IFN-γ, as measured in the equine IFN- γ ELISA. The 
endogenous sample was serially diluted 1:2 in sample diluent to form a 6-point dilution series, 
and a replicate dilution series was performed starting with a1000 pg/ml solution of rIFN-γ. 
Duplicate samples were assayed, plasma IFN-γ concentrations were calculated as described 
above, and results for both dilution series were analyzed by regression analysis. The ELISA 
linearity was characterized as the correlation coefficient (R2) value of the rIFN-γ regression. To 
determine the parallelism of the ELISA, regression slopes for the rIFN-γ and endogenous IFN-γ 
were compared using an F test (Graphpad Software, version 5).  
Assay repeatability and reproducibility were determined using plasma from three 
rhinoceros. For each animal, PWM samples were diluted 1:5 in pooled Nil plasma and assayed in 
triplicate on the same ELISA plate, as above. This was repeated daily for three days.  Intra-assay 




results for the three replicates on day one. Inter-assay precision (between-run reproducibility) 
was calculated as the CV of the results of the three daily assays. 
In order to determine the limit of detection (LOD) and limit of quantification (LOQ) of 
the ELISA, 24 replicates of sample diluent were analyzed on the same plate as a dilution series 
of rIFN-γ consisting of 7.8, 3.9, 2.0 and 1.0 pg/ml. For the 24 replicates, the mean OD value and 
standard deviation (SD) were calculated. The LOD (OD) was calculated as the mean value plus 3 
x SD and the LOQ (OD) was calculated as the mean plus 10 x SD (Armbruster et al., 2008). The 
values of these parameters as a concentration of rIFN-γ were then extrapolated from the standard 
curve by regression analysis. 
The final modified Mabtech Equine ELISAPRO protocol was performed as follows. The 
pre-coated plate was washed five times with 1x wash solution provided in the kit. Hereafter, 
serially diluted (2-fold dilutions in sample diluent) equine IFN-γ recombinant standard and 
rhinoceros plasma samples were added to duplicate wells (100 µl/well), and the plate incubated 
at 37◦C for two hours. After incubation and five washes, equine detection antibody, prepared at a 
1:500 dilution in sample diluent to a final concentration of 1 µg/ml, was added at 100 µl/well and 
the plate incubated at 37◦C for one hour. After five washes, 100 μl/well of streptavidin-HRP 
(1:1000 dilution) was added and incubated at 37◦C for one hour. After five washes, 100 μl of 
TMB enzyme substrate was added to each well and incubated in the dark at RT for 15 minutes. 
The reaction was stopped by addition of 100 μl/well stop solution (provided in kit). Results were 
determined as described above. 
Results 
Of the seven ELISA antibody pairs that were screened, the Mabtech bovine pair (kit 




PWM-stimulated blood of white rhinoceros. Moreover, compared with the three precoated 
ELISA systems, the in-house equine IFN-γ antibody pair had the greatest signal for PWM 
plasma, and this was selected for further evaluation as a precoated ELISA (Fig. 2.1).  
 
Figure 2.1 The comparative sensitivity of selected enzyme linked immunosorbent assays 
(ELISA) for rhinoceros IFN-γ. Whole blood from five rhinoceros was incubated overnight with 
pokeweed mitogen (10 ug/ml). Hereafter, pooled PWM rhinoceros’ plasma was diluted 1:8 and 
assayed using selected IFN-γ ELISAs. The Mabtech equine ELISA displayed the greatest mean 
OD for this sample. 
 
The Mabtech precoated equine ELISAPRO kit displayed a linear response for rIFN-γ 
concentrations ranging from 7.8 pg/ml to 125 pg/ml (R2 > 0.99), and this was consistent at 






Figure 2.2 Regression analysis of a dilution series of recombinant equine IFN-γ, ranging from 
7.8 to 125 pg/ml, and measured using the Mabtech Equine IFN-γ ELISAPRO kit assay, at room 
temperature (■), 30◦C (●) and 37◦C (▲). At all temperatures, the assay displayed a linear 
response (R2 > 0.99). 
 
Hereafter, to facilitate reproducibility between laboratories, since most laboratories have 
incubators set at 37°C and because high ambient temperatures may be present in laboratories 
where rhinoceros occur, the ELISA was performed at this temperature. The individual IFN-γ 
concentrations of Nil plasma samples were less than 8 pg/ml (data not shown) and mean 
recovery of rIFN-γ in these rhinoceros’ plasma was 93% in a 50% plasma sample and 88% in a 








Table 2.2 Recovery of recombinant equine interferon-gamma (IFN-γ) in three rhinoceros plasma 
matrices using the Mabtech Equine IFN-γ ELISAPRO kit assay.  
 Animal number Sample recovery  
50% plasma 25% plasma SD 
Animal 1 81 77 2.7 
Animal 2 96 94 0.8 
Animal 3 102 93 5.9 
Mean recovery % 93 88 3.5 
SD, standard deviation. 
 
Subsequently, rhinoceros plasma was assayed at a 1:2 dilution in kit sample diluent. The 
linear response of the ELISA for rIFN-γ was not significantly different from that of endogenous 









Figure 2.3 Regression analysis of dilution series of recombinant equine IFN-γ (A) and 
rhinoceros IFN-γ in plasma (B), ranging from 7.8 to 125 pg/ml, and measured using the Mabtech 
Equine IFN-γ ELISAPRO kit assay. Both samples displayed linear responses (R2 > 0.99) with no 




Using three different rhinoceros samples, intra-assay precision ranged from 0.4% to 2.8% 
and inter-assay precision ranged from 3.4% to 6.4% (Table 2.3). The LOD and LOQ were 
calculated as 1.5 and 5.4 pg/ml, respectively. However, because these extrapolated values were 
regarded as imprecise, the nearest empirical values, i.e. 2 pg/ml and 7.8 pg/ml, were accepted as 
the LOD and LOQ, respectively. 
 
Table 2.3 Intra-assay and inter-assay precisions of pokeweed mitogen-stimulated whole blood 
from three rhinoceros diluted in pooled Nil plasma assayed in triplicate for three days using the 
Mabtech Equine IFN-γ ELISAPRO kit assay. 
Animal number Intra-assay precision Inter-assay precision 
  Mean pg/ml SD CV Mean pg/ml SD CV 
Animal 1 111.0 1.7 1.6 104.0 6.2 5.9 
Animal 2 105.0 2.6 2.8 102.0 3.5 3.4 
Animal 3 112.0 0.6 0.4 104.0 6.7 6.4 
CV, coefficient of variation; SD, standard deviation. 
 
Discussion 
In this study, the Mabtech Equine IFN-γ ELISAPRO kit was selected as the optimal system 
for the measurement of white rhinoceros endogenous IFN-γ. When incubation steps were 
performed at 37◦C, the ELISA displayed good recovery of IFN-γ in a rhinoceros plasma matrix, a 
linear response to both recombinant equine IFN-γ and endogenous rhinoceros IFN-γ, and high 
reproducibility. 
Notably, the Equine IFN-γ ELISAPRO kit results displayed greater sensitivity than the 
bovine in-house ELISA previously used (Parsons et al., 2017). The identification of an equine 
ELISA as the optimal assay for measuring white rhinoceros IFN-γ was anticipated given the 




high homology of the interferon gamma sequences (Morar et al., 2007). Moreover, the antibodies 
used in this ELISA are known to cross-react with IFN-γ of other species 
(https://www.mabtech.com/knowledge-center/tutorials-and-guidelines/veterinary-reagents) and 
the use of ELISAs for IFN-γ detection in African wildlife has been previously reported (Goosen 
et al., 2014; Gormley et al., 2006). 
The ELISA incubation steps were performed at 37◦C in contrast to the manufacturer’s 
instructions. Rhinoceros typically are found in areas that are distant from environmentally 
controlled laboratories and temperature fluctuation could result in variation in ELISA results. 
Therefore, 37◦C was selected as the incubation temperature which can practically be achieved in 
most laboratories regardless of ambient temperatures. This temperature is utilized in a 
commercial cattletype® IGRA kit (Bernitz et al., 2018). A possible drawback of this protocol is 
that the LOQ of the ELISAPRO kit was calculated as 7.8 pg/ml, which is greater than that reported 
by the manufacturer. Nonetheless, the ELISA displayed a linear response across a wide range of 
temperatures (19-37◦C). These characteristics of the ELISAPRO kit highlight the utility of the 
assay for measuring rhinoceros IFN-γ under highly standardized conditions as applicable. The 
ELISAPRO kit showed excellent performance in measuring endogenous rhinoceros IFN-γ in 
plasma samples. Rhinoceros plasma showed minimal interference with the ELISA, and recovery 
of IFN-γ in this matrix was within the acceptable range of 80-120% (ICH Harmonised Tripartite 
Guideline, 2005). Moreover, parallelism was excellent, and ELISA responses were 
indistinguishable for recombinant equine and endogenous rhinoceros IFN-γ. This is in contrast to 
other African wildlife species such as warthogs, in which detection of IFN-γ in stimulated blood 
samples has proven difficult (Roos et al., 2018). In addition, intra-and inter-assay precision 




(Li et al., 2016), indicating the high reproducibility of the Mabtech Equine IFN-γ ELISAPRO kit. 
Therefore, this kit is well suited for measuring rhinoceros IFN-γ in clinical samples. However, 
further research is underway to investigate the diagnostic use of this ELISA assay for the 
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Mycobacterium bovis (M. bovis), the cause of bovine tuberculosis, is endemic in Kruger 
National Park (KNP), South Africa. The risk of spread of M. bovis infection currently prevents 
translocation of white rhinoceros (Ceratotherium simum) from this population. Therefore, 
accurate assays are necessary for screening this threatened species. Interferon gamma (IFN-γ) 
release assays (IGRA) are commonly used for tuberculosis diagnosis in humans and other 
wildlife species. Hence, the aim of this study was to develop an IGRA for M. bovis detection in 
white rhinoceros. Heparinized whole blood was collected from immobilized white rhinoceros in 
KNP (n=131) and incubated overnight in QuantiFERON®-TB Gold In-Tube (QFT) blood 
collection tubes, after which the plasma was harvested following centrifugation. Tissue samples 
for mycobacterial culture were available from a subset of 21 rhinoceros. The concentration of 
IFN-γ in plasma samples was measured using the Mabtech Equine IFN-γ ELISAPRO. An IGRA 
result was calculated as the difference in IFN-γ concentrations in the QFT Nil and TB antigen 
tubes. Using test results for the white rhinoceros with known infection status, a diagnostic cut-off 
value was calculated as 21 pg/ml. Additionally, cut-off values for IFN-γ concentrations for 
plasma from QFT Nil and QFT Mitogen tubes were calculated to increase confidence in IGRA 
result interpretation. The combination of the QFT stimulation platform and Mabtech equine IFN-
γ ELISA is a promising diagnostic test to distinguish between of M. bovis-infected and 










The white rhinoceros (Ceratotherium simum) is threatened (Emslie, 2012), and under 
severe poaching pressure. The largest populations of white rhinoceros are found in Kruger 
National Park (KNP), South Africa, where bovine tuberculosis (bTB) is endemic (Renwick et al., 
2007). Bovine tuberculosis is a chronic disease caused by infection with Mycobacterium bovis 
(M. bovis), a member of the pathogenic M. tuberculosis complex (MTBC) (Brosch et al., 2002). 
Although white rhinoceros are susceptible to infection with M. bovis, there remains a knowledge 
gap concerning the extent of infection in exposed populations (Miller et al., 2018). In order to 
improve our understanding of bTB in white rhinoceros and prevent the spread of the disease 
through translocation of infected animals, new diagnostic tools are required to accurately identify 
infected and possibly diseased individuals.  
Infection with M. bovis is usually diagnosed by detecting cell-mediated immune (CMI) 
responses towards pathogen-specific antigens (Welsh et al., 2005). This can be achieved by using 
an interferon-gamma (IFN-γ) release assay (IGRA) which includes antigenic stimulation of 
blood lymphocytes followed by measurement of the release of IFN-γ using an enzyme-linked 
immunosorbent assay (ELISA). Interferon-gamma is a commonly used cytokine biomarker for 
detection of MTBC infection and diagnostic IGRAs for detection of M. bovis infection have been 
developed for cattle (Bernitz et al., 2018), buffaloes (Goosen et al., 2014), and wild dogs (Higgitt 
et al., 2017). 
The QuantiFERON-TB Gold In-Tube (QFT) system was developed for a human IGRA 
which provides sterile blood collection tubes containing a peptide cocktail simulating the 
antigens early secreted antigenic target 6kDa protein (ESAT-6), culture filtrate protein 10 (CFP-




for field testing of African wildlife because they are easy to use, provide high diagnostic 
specificity (Parsons et al., 2011), and can be adapted for use in multiple species (Bernitz et al., 
2018; Higgitt et al., 2017; Roos et al., 2018). In addition, the QFT system has been previously 
used by Parsons et al. (2017) to measure immune sensitization of white rhinoceros to M. bovis. 
Therefore, the aim of this study was to describe a diagnostic QFT IGRA for detection of M. 
bovis infection in white rhinoceros by combining the commercially available QFT stimulation 
platform with a validated rhinoceros IFN-γ ELISA (Chileshe et al., 2019). This optimized IFN-γ 
ELISA was selected based on phylogenetic relationship between rhinoceros (Chileshe et al., 
2019; Steiner and Ryder, 2011) and equine species and the high homology of the IFN-γ 
sequences (Morar et al., 2007). 
Materials and Methods 
Animals and samples 
Whole blood was collected opportunistically in heparinized tubes (BD Biosciences, 
Franklin Lakes, NJ, USA) from 131 chemically immobilized white rhinoceros in KNP between 
2015 and 2018, as previously described (Miller et al., 2018), during routine management or other 
approved activities. Twenty-one of these animals were subsequently euthanized due to severe 
poaching wounds. From these 21 rhinoceros, post-mortem tissue samples were collected 
(specifically, submandibular, retropharyngeal, cervical, prescapular, axillary, inguinal, 
mediastinal, tracheobronchial, mesenteric lymph nodes and lung) and frozen for transport to the 
lab, as previously described (Miller et al., 2018). All samples were processed for mycobacterial 
culture using the BACTEC™ MGIT™ 960 system (BD Biosciences) as described by Goosen et 




of difference analysis (Warren et al., 2006). Results were used to define animals as M. bovis-
infected if any tissue was culture-positive, or uninfected if all tissues were culture-negative.  
Also included in this study, 10 archived plasma sample sets obtained from 2 white 
rhinoceros that had been experimentally infected with M. bovis and tested monthly using the 
QFT system, as previously described (Parsons et al., 2017). These two white rhinoceros were 
included in the M. bovis-infected cohort. 
Interferon gamma (IFN-γ) release assay (IGRA) 
One ml aliquots of heparinized whole blood were incubated in tubes of the QFT system 
(Qiagen, Venlo, Limburg, Netherlands) comprising a Nil tube (containing saline) and a TB 
Antigen (TB Ag) tube containing mycobacterial peptides (ESAT6, CFP10, TB7.7). Additionally, 
one ml aliquots were incubated in either QFT Mitogen tubes (n = 90) or in tubes containing 
pokeweed mitogen (PWM, Sigma-Aldrich, St. Louis, MO, USA) at a final concentration of 10 
µg/ml (n = 41). All tubes were incubated for 24 h at 37°C. After incubation, plasma was 
harvested following centrifugation at 800 x g for 10 min, transferred into a 2 ml microcentrifuge 
tube, and stored at -80°C until analysis.  
All plasma samples, including samples from the experimentally infected animals, were 
analyzed using the equine IFN-γ ELISAPRO kit (Mabtech Ab, Nacka Strand, Sweden; custom 
precoated plates using kit reagent product 3117-1H-6) as previously described (Chileshe et al., 
2019). The IFN-γ concentrations in plasma from the Nil, TB Ag and mitogen tubes were defined 
as [IFN-γNil], [IFN-γTB], [IFN-γMit], respectively, and the QFT interferon gamma release assay 







The QFT test values of the culture-confirmed naturally M. bovis-infected and uninfected 
rhinoceros (n = 21) were compared using the unpaired Student t-test. A p value of 0.05 was used 
to determine statistical significance. 
A receiver operator characteristic (ROC) curve analysis was performed to determine the 
optimal diagnostic cut-off value for the QFT assay, calculated as the value that yielded the 
highest Youden’s index (Youden, 1950). Hereafter, alternative cut-off values for the QFT assay 
were evaluated in the remaining 110 free-ranging rhinoceros (without culture results) by 
comparing the proportion of animals testing positive for each alternative value to the proportion 
testing positive using the ROC derived cut-off. This was done using a Z test (GraphPad 
Software, version 5, Inc., La Jolla, CA, USA). For this analysis, a stringent p value of ≤ 0.01 was 
considered statistically significant. In order to ensure the validity of future tests, exclusion 
criteria for the QFT Nil and QFT Mitogen samples were calculated as the 95th percentile of all 
[IFN-γNil] values (n=131) and the 5th percentile of all [IFN-γMit] values (n=90), respectively. The 
cut-off values were used to determine thresholds for negative (QFT Nil) and positive (QFT 
Mitogen) control samples. 
Results 
Of the 21 white rhinoceros that had mycobacterial culture results, 8 were M. bovis 
culture-positive and 13 were negative. The 21 test results for these animals are shown in Figure 
3.1. The mean QFT IGRA value for M. bovis-infected animals (n=8) was significantly greater 





Figure 3.1 The QuantiFERON-TB Gold In-Tube interferon gamma release assay results for M. 
bovis-infected and uninfected white rhinoceros, showing a significant difference between the 
means of these groups (unpaired Student t-test  p = 0.04).  Means and 95% confidence intervals 
are shown by horizontal bars. 
 
Based on ROC curve analysis, the optimal QFT IGRA cut-off value was 21 pg/ml (Se = 






Figure 3.2 Receiver operating characteristics curve analysis of QuantiFERON-TB Gold In-Tube 
interferon gamma release assay results for Mycobacterium bovis-infected and uninfected white 
rhinoceros (Area Under the Curve = 0.84; 95% CI, 0.70-0.98; p < 0.001).  
 
Using this cut-off value, 21 out of 110 (19 %) white rhinoceros (with no culture results) 
were test positive. The distribution of QFT IGRA responses for M. bovis-exposed rhinoceros is 
shown in Figure 3.3. The proportion of animals testing positive using a cut-off value of 21 pg/ml 
was compared with the proportion of animals testing positive using proposed positive cut-off 
values (as listed in column 1, Table 3.1). Cut-off values lower than 21 pg/ml and greater than 61 




Table 3.1 Test performance of the QuantiFERON-TB Gold In-Tube interferon gamma release assay, for selected cut-off values as 











95 % CI 
Youden's Index 
% 
1 78 52.3% to 93.5% 69 38.5% to 90.9% 47 
2 78 52.3% to 93.5% 77 46.1% to 94.9% 55 
5 78 52.3% to 93.5% 85 54.5% to 98.1% 62 
21a 78 52.3% to 93.5% 92 63.9% to 99.8% 70 
35 72 46.5% to 90.3% 92 63.9% to 99.8% 65 
36 61 35.7% to 82.7% 92 63.9% to 99.8% 53 
41 61 35.7% to 82.7% 100 75.3% to 100% 61 
48 56 30.7% to 78.4% 100 75.3% to 100% 56 
54 50 26.0% to 73.9% 100 75.3% to 100% 50 
61 44 21.5% to 69.2% 100 75.3% to 100% 44 
69 39 17.3% to 64.2% 100 75.3% to 100% 39 
77 33 13.3% to 59.0% 100 75.3% to 100% 33 
85 28 9.6% to 53.4% 100 75.3% to 100% 28 
99 22 6.4% to 47.6% 100 75.3% to 100% 22 
112 17 3.5% to 41.4% 100 75.3% to 100% 17 
121 11 1.3% to 34.7% 100 75.3% to 100% 11 
272 6 0.1% to 27.2% 100 75.3% to 100% 6 






Figure 3.3 QuantiFERON-TB Gold In-Tube interferon gamma release assay values of 110 M. 
bovis-exposed white rhinoceros from Kruger National Park. The optimal cut-off value of 21 
pg/ml is indicated by the dotted line (------) and alternative cut-off value of 61 pg/ml indicated by 
straight line (––––). 
 
In order to determine exclusion criteria for the QFT IGRA, the 95th percentile of all 
[IFN-γNil] values were calculated as 28 pg/ml and the 5th percentile of [IFN-γMit] values as 84 










Table 3.2 Interpretation criteria for the QuantiFERON-TB Gold In-Tube interferon gamma 
release assay. 
 
Test result [IFN-γNil] 
 
[IFN-γ Mit] [IFN-γTB] minus [IFN-γNil]  
Negative < 28 pg/ml AND > 84 pg/ml    AND < 21 pg/ml 
Positive 
Re-test 
< 28 pg/ml 
< 28 pg/ml 
AND 
AND 
> 84 pg/ml   AND 
> 84 pg/ml   AND 
> 62 pg/ml 
21-61 pg/ml 
Inconclusive > 28 pg/ml OR < 84 pg/ml    N/A 
 IFN-γ, interferon gamma; [IFN-γNil] concentration in nil tube; [IFN-γMit], concentration in Mitogen tube; 
[IFN-γTB], concentration in TB antigen tube; N/A, not applicable  
 
Discussion 
In this study, a new diagnostic IGRA, combining the QFT stimulation platform and 
Mabtech Equine IFN-γ ELISAPRO kit, was evaluated for detection of M. bovis infection in white 
rhinoceros. The IGRA results for M. bovis-infected animals were significantly greater than those 
for uninfected animals, indicating that it could be used to distinguish between these groups. The 
optimal cut-off value was calculated as 21 pg/ml of antigen-specific IFN-γ. In addition, we 
calculated cut-off values for IFN-γ concentrations for plasma from QFT Nil and QFT Mitogen 
tubes to increase confidence in IGRA result interpretation.  
 White rhinoceros with confirmed M. bovis infection status were used to determine the 
diagnostic cut-off value. The value of 21 pg/ml is similar to cut-off values determined for QFT 
IGRAs in wild dogs (51 pg/ml) (Higgitt et al. 2019), African buffaloes (66 pg/ml) (Parsons et al., 
2011), and humans (18 pg/ml) (Ruhwald et al., 2007). Therefore, this diagnostic cut-off value 
appears appropriate for white rhinoceros. However, the low number of animals used for this 
analysis, and the wide confidence intervals obtained for test parameters, suggests that this value 
should be considered as a preliminary finding. However, in a larger cohort, QFT test outcomes 




35 to 61 pg/ml. For these reasons, we propose that QFT IGRA results be interpreted as follows: a 
test result < 21 pg/ml indicates that the rhinoceros is uninfected; a test result > 62 pg/ml, that the 
rhinoceros has detectable immune sensitization to M. bovis antigens, consistent with infection; 
and results ranging from 21 – 61 pg/ml should be considered suspect for infection. Interpretation 
of the latter should be informed by epidemiological data and risk management considerations. 
Therefore, serial testing is recommended since a single result only provides an insight into the 
current status and not progression of initial infection.  
In order to confirm the validity of test results, cut-off values for the QFT Nil and QFT 
Mitogen samples were calculated as < 28 pg/ml and > 84 pg/ml, respectively. The latter value is 
stringent when compared to the human QFT and Qiagen Cattletype® IGRAs that use cut-off 
values for mitogen samples that are similar to the diagnostic cut-off value (Ruhwald et al., 2007; 
Bernitz et al., 2018). The interpretation criterion for the mitogen sample is important for 
confirming viability and function of cells throughout the stimulation process. Individual 
rhinoceros samples with QFT Mitogen values that do not have an IFN-γ concentration > 84 
pg/ml should be excluded since a negative QFT IGRA value cannot be reliably interpreted as 
negative. With regards to background IFN-γ concentration in the QFT Nil sample, high 
nonspecific values may occur if there is a technical issue in blood processing or if the individual 
has other conditions causing in vivo immune stimulation (Pai et al., 2014). Therefore, these cut- 
off values provide increased confidence in test interpretation. 
The QFT IGRA has shown utility for screening white rhinoceros to detect M. bovis 
infection. In addition, this IGRA is easy to use and incorporates commercially available reagents 
to improve reproducibility. Notably, the use of the prepared tubes of the QFT stimulation 




Limitations of the study included the low number of culture-confirmed white rhinoceros 
in the M. bovis-infected and uninfected groups. Also, the true infection status of the larger cohort 
of 110 white rhinoceros was unconfirmed. This highlights the difficulty of validating diagnostic 
tests in threatened species with few individuals with confirmed infection. In addition, a test result 
< 21 pg/ml indicates that the rhinoceros is uninfected, although it could be an early infection that 
has not yet resulted in a detectable immune response. With a test result > 62 pg/ml, the 
rhinoceros has detectable immune sensitization to M. bovis antigens, consistent with infection, 
although it could also have recently cleared infection.  
In conclusion, this study shows the combination of the QFT stimulation platform and 
Mabtech Equine IFN-γ ELISAPRO is a promising diagnostic test for the detection of M. bovis 
infection in white rhinoceros. However, further research is necessary to recalculate the cut-off 
value of this assay using a ROC curve analysis with samples from larger infected and unexposed 
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Bovine tuberculosis (bTB), caused by Mycobacterium bovis (M. bovis) infection, disrupts 
conservation programs of threatened species such as the white rhinoceros (Ceratotherium 
simum). Interferon gamma release assays have been developed for the diagnosis of M. bovis 
infection in rhinoceros, however, the discovery of additional diagnostic biomarkers might 
improve the accuracy of case detection. The aim of this pilot study was therefore to evaluate a 
novel unbiased approach to candidate biomarker discovery and preliminary validation. Whole 
blood samples from 12 white rhinoceros were incubated in Nil and TB antigen tubes of the 
QuantiFERON® TB Gold In-Tube (QFT) system after which RNA was extracted and reverse 
transcribed. Using the equine RT2 profiler PCR array, relative gene expression analysis of 
samples from two M. bovis immune sensitized rhinoceros identified CCL4, CCL8, IL23A, LTA, 
NODAL, TNF, CSF3, CXCL10 and GPI as upregulated in response to antigen stimulation. Novel 
gene expression assays (GEAs) were designed for selected candidates, i.e. CCL4, CXCL10 and 
IFNG, and analysis of QFT-processed samples showed the CXCL10 GEA could distinguish 
between five M. bovis-infected and five uninfected rhinoceros. These findings confirm the value 
of the equine RT2 profiler PCR array as a useful tool for screening biomarkers for the diagnosis 













Bovine tuberculosis (bTB) caused by Mycobacterium bovis (M. bovis) is endemic in the 
Kruger National Park (KNP), South Africa (Miller et al., 2017). The presence of disease in this 
park has disrupted conservation programs by restricting translocations of wildlife and may also 
have an impact on the health of infected animals (Emslie, 2011; Miller et al., 2018). The first 
case of M. bovis infection in rhinoceros in KNP was recorded in 2016 (Miller et al., 2017) with 
additional cases reported subsequently (Miller et al., 2018). The current management plan for 
bTB screening in rhinoceros in KNP relies on ante-mortem testing to identify infected animals 
before translocation, thereby reducing the risk of introducing M. bovis into new ecosystems (P. 
Buss pers. comm).  
Ante-mortem tests for the diagnosis of bTB are based on detecting cell-mediated immune 
(CMI) responses. In rhinoceros, the equine interferon gamma (IFN-γ) ELISAPRO kit (Mabtech 
Ab, Nacka Strand, Sweden) has been validated to measure antigen-specific cytokine release 
using the QuantiFERON® TB Gold In-Tube (QFT) system for stimulation of whole blood 
(Chileshe et al., 2019). The QFT system uses mycobacterial peptide antigens early secretory 
antigenic target 6 kDa (ESAT-6) and culture filtrate protein 10 kDa (CFP-10) to provide 
specificity to the IFN-γ release assay (IGRA). However, studies in other species have shown that 
cytokine biosignatures provide greater diagnostic accuracy than a single analyte (Bernitz et al., 
2019; Palmer et al., 2020). Therefore, there is a need to investigate additional biomarkers for 
detection of M. bovis infection in rhinoceros. 
Antigen-induced cytokine gene expression, measured by reverse transcription 
quantitative polymerase chain reaction (RT-qPCR), has been used to identify potential 




approach may be useful for wildlife where there is a lack of species-specific reagents (de Lisle et 
al., 2002). For example, gene expression assays (GEAs) using candidate biomarkers in the CXCL 
family have shown promise as diagnostic tools in different wildlife species (Olivier et al., 2015; 
Higgitt et al., 2017; Roos et al., 2019). Therefore, the aim of this study was to investigate GEAs 
as tools to identify potential biomarkers of M. bovis infection in white rhinoceros. 
Materials and Methods 
Animals, sample collection and blood stimulation 
Samples were collected from 12 white rhinoceros originating from the KNP as previously 
described (Chileshe et al., 2019). Two animals that had previously been confirmed to be 
immunologically sensitized to M. bovis antigens (R1 and R2), based on the validated interferon-
gamma release assay, provided convenient blood samples for initial biomarker discovery. 
Additionally, blood and tissue samples were opportunistically collected from severely injured 
animals that were euthanized for welfare reasons (R3 – R12). Mycobacterial cultures, performed 
on tissue samples as previously described (Miller et al., 2018), were used to classify animals as 
either M. bovis-infected (n = 5) or uninfected (n = 5).  
Whole blood was collected in heparinized vacutainer tubes (BD Biosciences, Franklin 
Lakes, NJ, USA) as previously described (Chileshe et al., 2019). Within 6 h of collection, one ml 
of heparinized blood was added to each tube of the QuantiFERON® TB Gold Plus (In-Tube) 
system (QFT) (Qiagen, Venlo, The Netherlands), comprising a Nil tube (QFT Nil, containing 
saline) and the TB2 antigen tube (QFT TB, containing ESAT-6 and CFP-10 peptides). Samples 
from R1 and R3-R12 were incubated for 24 hours at 37°C, while samples from R2 were 




and centrifuged at 800 x g for 10 min. Plasma was harvested and the cell pellets resuspended in 
1.3 ml RNAlater® (Ambion, Austin, TX, USA) and stored at -80°C until analyzed. 
RNA extraction  
The RNAlater®-stabilised samples were centrifuged at 15 000 × g for 2 min and the 
supernatant discarded before RNA was extracted from the remaining pellet using the RiboPure™ 
Blood Kit (Ambion), then eluted in a volume of 60 µl, according to the manufacturer’s 
guidelines. Total RNA concentration (ng/µl) and quality (A260/A280 and A260/A230 ratio) 
were measured using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA).  
Biomarker screening using the equine RT2 profiler™ PCR array 
The QFT Nil and QFT TB antigen samples for R1 (24 hours) and R2 (6 hours) were 
analysed using the equine RT2 profiler PCR array (Qiagen). This quantitative real-time (RT-
qPCR) array consists of expression assays for 84 cytokine genes, 5 reference genes, a genomic 
DNA control, a reverse-transcription control, and a PCR reagents control. The assay was 
performed according to the manufacturer’s instructions. Briefly, 200 ng of RNA from each 
sample of 60 µl was treated for genomic DNA (gDNA) with DNA elimination mix and reverse-
transcribed using the RT2 First Strand Kit (Qiagen), in a final volume of 20 µl. The PCR reaction 
mix for each cDNA sample was prepared using the RT2 SYBR Green qPCR Mastermix (Qiagen) 
in a final volume of 1300 µl. Ten µl of the reaction mix was dispensed into duplicate wells of a 
384-well plate format using an automated electronic pipette (epMotion®, Eppendorf, Hamburg, 
Germany).  
The RT-qPCR was initiated at 95°C for 10 min followed by 50 cycles at 95°C for 15 s and 




and quantification cycle (Cq) values for each assay were automatically determined. For each 
animal, the difference in gene expression in the QFT TB Antigen sample, relative to the QFT Nil 
sample was calculated according to the manufacturer’s instructions using the ΔΔCq method 
(Livak and Schmittgen, 2001). Potential candidate targets were selected for further analysis 
based on (i) intra-assay variability of < 5% and (ii) to limit the number of potential biomarkers 
identified, we chose a fold change cut-off value for upregulated cytokines following antigen 
stimulation of > 2 in either R1 or R2. The RT-qPCR products for R2 were visualized in a 1% 
agarose gel (Lonza Group, Basel, Switzerland) by electrophoresis. 
Sequencing of selected white rhinoceros gene transcripts 
Based on findings from the RT2 profiler, as described below, candidate biomarkers were 
selected for further analysis by RT-qPCR, i.e. CCL4 and CXCL10. In addition, IFNG was 
included since interferon-gamma protein (IFN-γ) has been shown to be a biomarker for M. bovis 
infection in rhinoceros (Chileshe et al., 2019). The gene YWHAZ was selected as a reference 
transcript as its expression is stable in whole blood of numerous other species (Olivier et al., 
2015; Higgitt et al., 2017; Roos et al., 2019). In order to confirm that published messenger RNA 
(mRNA) sequences of the white rhinoceros were valid, CXCL10, CCL4, IFNG, and YWHAZ 
sequences of the domestic horse and white rhinoceros were obtained from the National Center 
for Biotechnology Information (NCBI, https://www.ncbi.nlm.nih.gov) and aligned using Clustal 
Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Using the Primer3Plus online tool 
(http://primer3plus.com/cgi-bin/dev/primer3plus.cgi), forward and reverse PCR primers were 
designed to anneal to regions with high homology (Table 4.1).  
Partial or complete coding sequences of these transcripts were amplified from samples of 




transcribed from 200 ng total RNA using QuantiTect Reverse Transcription kit; Qiagen), 12.5 µl 
of OneTaq® Hot Start 2x Mastermix with Standard Buffer (New England BioLabs® Inc., Ipswich, 
MA, USA), 0.5 µl of each gene-specific forward and reverse primer (final concentration of 0.2 
µM; Integrated DNA Technologies, Coralville, IA, USA) and 10.5 µl nuclease-free water. The 
reaction was initiated at 94°C for 2 min, followed by 45 cycles of 94°C for 30 s, a PCR-specific 
annealing temperature (Table 4.1) for 30 s, and an extension step of 68°C for 1 min, and 
concluded with a final extension step at 68°C for 10 min using a Veriti™ 96-Well Thermal 
Cycler (Applied Biosystems).  
The qPCR products, visualized in a 1% agarose gel (Lonza Group) by electrophoresis, 
were submitted to the Central Analytical Facility (Stellenbosch University, Stellenbosch, South 
Africa) for sequencing using a 3130xl Genetic Analyzer (Applied Biosystems), according to the 
manufacturer’s guidelines, and analysed using Sequencher software version 5.4.6 (Gene Codes, 
Ann Arbor, MI, USA). The resulting white rhinoceros mRNA sequences were submitted to the 
GenBank® genetic sequence database (http://www.ncbi.nlm.nih.gov/genbank/) (Table 4.1). 
qPCR design and evaluation of biomarkers using qPCR assays  
 For the white rhinoceros mRNA sequences, putative exon-exon boundaries and intron 
sizes were inferred from domestic horse sequences obtained from the Ensembl Genome Browser 
(http://www.ensembl.org/index.html). Primer3 online software was used to design 









Table 4.1 Reference sequence accession numbers, primer sequences, and annealing temperatures of PCRs used to amplify selected 
white rhinoceros mRNA targets. 
Gene   
NCBI accession No. 
    
Primer sequence (5’-3’) 
T 
(°C)   
  Horse Rhinoceros  Forward Reverse  
CCL4   XM_001503888  XM_004434846  GCACCAATGGGCTCAGAC TCACAAAGTTGCGAGGAAGC 60 
CXCL10  NM_001114940  XM_004430848  CACGTTTTCTGAGACACTGCTC CAAGGGATCTTTCCACCTCT 60 
IFNG    NM_001081949 XM_004429381  GTCCTTGGGACCTGATCAGC TTGGGTGCAGTCACAGTTGT 65 
YWHAZ  XM_001492988  XM_004431216 GAAAGGTCCCGGATGTTGCT GGGGCTCAGCAGGCTCTG 65 
T, annealing temperature  
 
Table 4.2 Reference sequence accession numbers, primer sequences, and selected parameters of RT-qPCRs for transcripts of the 
white rhinoceros. 
Gene   
NCBI accession No. Primer sequence (5’-3’) 
 DM 




  Forward Reverse    
CCL4  MT465464;MT465465 CTCTCAGCACCAATGGGCTCAG GCTTCCTCGCAACTTTGTGA 81 104 1.32 
CXCL10 MT465462;MT465463 CCACGTGTTGAGATCATTGCC AATTCTGGATGGTCTGGGACTC 76 112 2.47 
IFNG   MT465460;MT465461  GAAGAACTGGAAAGAGGAGAGTG TCCATGCTCTTTTGAATGACCTG 78.5 108 1.97 
YWHAZ   MT465466 TGGTGACAAGAAAGGGATTG ACAGAGAAGTTAAGGGCCAGAC 76.5 105 1.79 







All qPCRs were performed in triplicate using a CFX96 Touch™ Real-Time PCR 
Detection System (Bio-Rad Laboratories Inc., Hercules, CA, USA) and consisted of 10 µl 
iTaq™ Universal SYBR® Green Supermix (Bio-Rad), 1 µl of each gene-specific forward and 
reverse qPCR primer (at a final primer concentration of 0.5 µM; Integrated DNA Technologies), 
2 µl of cDNA, and 6 µl of nuclease-free water. The reaction was initiated at 95°C  for 30 s, 
followed by 40 cycles of 95°C for 5 s and 60°C for 30 s, and concluded with a standard melt-
curve analysis which was used to confirm the specificity of subsequent qPCRs. Initially, qPCR 
products were visualized in a 1% agarose gel and sequenced as described above. In order to 
determine the efficiencies of each qPCR, a dilution series (1:5, 1:25, 1:125, 1:625, 1:3125) of a 
pooled cDNA sample was assayed and analysed as previously described (Pfaffl et al., 2001). To 
validate the use of the relative quantification method, amplification efficiencies of YWHAZ and 
target genes were compared as previously described (Livak and Schmittgen, 2001). For each of 
the five M. bovis-infected and five uninfected rhinoceros, RT-qPCRs were performed in 
triplicate for the reference and each of the target genes using cDNA derived from blood 
incubated in QFT Nil and QFT TB antigen tubes.  
Data analysis 
 To determine the intra-assay variability of replicate reactions of each qPCR, the 
coefficient of variation (CV) was calculated for each sample and reported as the mean of all 
samples (n = 20). For each sample, the relative expression of each target gene was normalised by 
subtracting the Cq value of YWHAZ from the Cq value of the target gene in order to calculate the 
relative abundance of the target gene mRNA for each sample (i.e. ΔCq). Thereafter, the ΔCq 
value derived from the QFT Nil sample was subtracted from the ΔCq value derived from the 




a QFT GEA result as a measure of difference in expression of the target transcript in response to 
antigen stimulation (Livak and Schmittgen, 2001).  
The GEA results for all target genes were then analysed in GraphPad Prism version 5 
(GraphPad Software Inc., La Jolla, CA, USA). A Mann-Whitney U-test was used to determine if 
there was a difference in results for each gene between five M. bovis-infected and five uninfected 
rhinoceros. Results with a p value < 0.05 were considered statistically significant. 
Results 
The RNA yields from blood incubated in the QFT TB Antigen and QFT Nil tubes ranged 
from 21 – 193 ng (mean of 52 ng) with a mean A260/A280 ratio of 1.84 (range: 1.53 – 2.09) and 
a mean A260/A230 ratio of 1.43 (range: 0.78 – 2.38). For the equine RT2 profiler assay, 
electrophoresis of RT-qPCR products revealed clear and reproducible bands of 80 to 200 base 
pairs for four of five reference genes, i.e. ACTB, B2M, HPRT1, and LOC100056766. Duplicate 
assays of these genes showed a CV of < 5% and these four reference genes were therefore used 
to normalize relative expression calculations (Supplementary Table 1 and 2). In addition, Cq 
values of the RT2 profiler controls were all within the manufacturer’s recommended ranges (data 
not shown). A total of 32 genes were successfully amplified in R1 (Supplementary Table 1) and 






Table 4.3 Selected equine RT2 profiler assay results, for two white rhinoceros, using mRNA isolated from whole blood processed 
with the QuantiFERON® TB Gold In-Tube system (QFT). 










 Mean target Cq Mean Ref Cq ΔCq  ΔΔCq 
Fold Change 
(2-ΔΔCq) 
R1  CCL4 18.2 22.3 -4.0  19.1 21.4 -1.9 
 -2.1 4.3 
  CCL8 30.7 22.3 8.5  32.2 21.4 11.2 
 -2.6 6.3 
  IL23A 29.2 22.3 7.0  29.7 21.4 8.7 
 -1.7 3.2 
  LTA 28.5 22.3 6.2  29.9 21.4 8.5 
 -2.2 4.7 
  NODAL 29.0 22.3 6.7  30.2 21.4 8.7  -2.1 4.1 
  TNF 25.7 22.3 3.4  26.2 21.4 5.2 
 -1.7 3.3 
R2   CCL4 25.7 23.9 1.9  28.2 24.2 4.1 
 -2.2 4.7 
  CSF3 34.3 23.9 10.5  37.6 24.2 13.5 
 -3.0 7.9 
  CXCL10 33.8 23.9 10.0  36.3 24.2 12.2 
 -2.2 4.6 
    GPI 28.1 23.9 4.2   30.1 24.2 5.9   -1.7 3.3 
 
CV, Coefficient of variation; Ref, Reference genes; QFT TB, QFT TB antigen tube containing ESAT-6 and CFP-10 peptides; QFT Nil (containing 











Two of these potential candidates were selected for further analysis using RT-qPCR 
assays, i.e. CXCL10 since this has shown promise in numerous species and CCL4 because it was 
identified in both R1 and R2. In addition, IFNG was included because there is a validated IGRA 
for TB diagnosis in white rhinoceros. Sequenced gene transcripts for CCL4, CXCL10, IFNG and 
YWHAZ showed high homology with published white rhinoceros sequences (Table 4.2).  
All RT-qPCRs displayed low intra-assay variability with characteristic melt curves (data 
not shown) and melt peaks (Table 4.2). In addition, amplification efficiencies ranged from 104 to 
112% (Table 4.2) and the relative efficiencies of all target gene qPCRs were confirmed to be 
similar to the reference gene (data not shown). No products were obtained in the no-RT and no-
template control reactions. Visualization following gel electrophoresis and sequencing of qPCR 
products confirmed the amplification of appropriate targets (data not shown).  
 In samples from M. bovis-infected rhinoceros, CXCL10 showed a significant 
upregulation in response to antigen stimulation compared to samples from uninfected rhinoceros 
(Fig. 4.1). The median fold increases in antigen-specific CXCL10 expression for the M. bovis-
infected and uninfected animals were 20.5 and 1.6, respectively (Fig. 4.1). In contrast, no 





Figure 4.1 Test results for QuantiFeron TB Gold In-Tube gene expression assays targeting IFNG (A), CXCL10 (B) and CCL4 (C), for 
M. bovis-infected and uninfected rhinoceros. The CXCL10 assay results were significantly greater for M. bovis-infected rhinoceros 





This study describes the successful amplification of white rhinoceros cytokine gene 
transcripts from whole blood using the equine RT2 profiler array. Using this assay, nine genes 
were identified as potential biomarkers of antigen recognition in blood incubated in the QFT 
stimulation system. In addition, novel RT-qPCR assays were developed to further evaluate these 
cytokine targets. Using this approach, measurement of CXCL10 expression was confirmed to be 
able to distinguish between M. bovis-infected and uninfected white rhinoceros. 
Seven of the genes identified by the equine RT2 profiler array as displaying antigen-
specific expression, i.e. CCL4, CCL8, CSF3, CXCL10, IL23A, LTA and TNF, have all previously 
been associated with both mRNA and protein biomarkers of mycobacterial infection and disease 
in humans and animals. In particular, CXCL10 expression (encoding IP-10) is a highly sensitive 
diagnostic biomarker of TB in humans (Ruhwald et al., 2008) and other species (Roos et al., 
2018; Bernitz et al., 2019) and is discussed, as is CCL4, in greater detail below. Similarly, 
antigen-induced TNF expression (detected as either mRNA or protein) is a TB biomarker 
common to humans and acttle but is diagnostic of disease severity rather than infection (Thacker 
et al., 2007; Sutherland et al., 2010; Wang et al., 2013). In contrast, while protein products of 
CSF3 and IL23A expression protein have been identified as biomarkers of TB disease in humans 
(Sutherland et al., 2010; Wei et al., 2015), this is the first report of expression of these genes as 
candidate biomarkers in an animal species. The expression of CSF3 and IL23A are both closely 
associated with IL17 (Stark et al., 2005), which has been described as a diagnostic biomarker in 
cattle (Blanco et al., 2011; Waters et al., 2016). The need for species-specific studies is 
highlighted by CCL8 (which encodes the protein MCP-2), the expression of which has shown 




M. bovis infection in African buffaloes (Goosen et al., 2014).  Multiplex gene expression assays 
have the advantages of screening large numbers of potential target genes using limited samples 
and have been widely used for biomarker identification as well as diagnostic applications 
(Shukla et al., 2018; Palmer et al., 2020). Given the scarcity of samples from M. bovis-sensitized 
white rhinoceros and the lack of species-specific reagents, these findings support the use of the 
equine RT2 profiler as a useful tool for screening analytes for the diagnosis of M. bovis infection 
in rhinoceros. 
Of the candidate biomarkers selected for further evaluation by RT-qPCR, only antigen-
specific CXCL10 expression distinguished between M. bovis-infected and uninfected rhinoceros. 
This finding contrasts with reports that measurement of antigen-induced IFN-γ protein release is 
diagnostic of M. bovis infection in this species (Parsons et al., 2017; Chileshe et al., 2019).  
Similarly, measurement of CXCL10 gene transcription, rather than that of IFNG, has shown 
promise as a diagnostic biomarker in other animal species such as lions (Olivier et al., 2015) and 
spotted hyena (Crocuta crouta) (Higgett et al., 2017). This may be related to differences in the 
kinetics of gene expression of these markers or the relative abundance of effector cells 
expressing these transcripts (Ruhwald et al., 2007). Importantly, the expression of CXCL10 
protein (IP-10) during antigen-induced immune activation is a sensitive and valuable biomarker 
of TB diagnosis in humans (Ruhwald et al., 2008), African buffaloes (Goosen et al., 2015), 
warthogs (Roos et al., 2018) and cattle (Parsons et al., 2016; Coad et al., 2019; Palmer et al., 
2020). These studies strongly support the present findings that CXCL10/IP-10 should be further 
investigated as a diagnostic biomarker of M. bovis infection in rhinoceros.  
Despite CCL4 initially showing promise as a candidate biomarker of antigen recognition, 




and uninfected rhinoceros. This gene encodes for MIP-1β, which, in combination with other 
cytokines, has been identified as a biomarker of TB disease in humans when measured in both 
unstimulated and antigen-stimulated blood (Chegou et al., 2009). However, MIP-1β levels are 
also elevated in unstimulated plasma from human patients with other respiratory diseases 
(Chegou et al., 2018) and antigen-stimulated samples of healthy controls (Wei et al., 2015). This 
might, in part, explain the discrepancy in the results obtained using the RT2 profiler and RT-
qPCR assays. While CCL4 may display antigen-induced upregulation, the present findings do 
not support further investigation of this cytokine as a diagnostic marker of M. bovis infection in 
rhinoceros.  
A major limitation for the optimal measurement of antigen-induced gene transcription of 
activated lymphocytes and other immune cells is the dynamic nature of this process. Gene 
expression may be induced directly by lymphocyte antigen recognition (e.g. IFNG), or indirectly 
in response to cytokine release (e.g. CXCL10), resulting in gene-specific expression kinetics 
(Abdalla et al., 2003). For this reason, sample incubation times must be optimized for assays 
designed to measure specific targets (Bibova et al., 2012). In cases where numerous gene 
transcripts are analysed, no single incubation time will be optimal, and multiple sampling time 
points post-infection can be of value (Palmer et al., 2020). This is supported by findings from the 
present study in which different targets were identified after 6 and 24 h of sample incubation. 
In conclusion, despite limitations in this pilot study, the target gene CXCL10, identified 
by the RT2 profiler, was confirmed as a promising biomarker by demonstrating significant 
upregulation in antigen-stimulated blood from M. bovis-infected rhinoceros in a novel cytokine 




for M. bovis infection in rhinoceros; future studies should investigate optimizing these assays in 
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Interferon gamma (IFN-γ)-induced protein 10 (IP-10) has shown promise as a diagnostic 
biomarker of mycobacterial infection in humans, cattle, and African wildlife. The aim of this 
pilot study was to evaluate IP-10 as an additional biomarker to interferon gamma in order to 
increase accuracy in interpreting results to diagnose M. bovis infection in white rhinoceros. 
Archived plasma sample sets stored at -80°C, harvested from whole blood incubated in 
QuantiFERON TB Gold Plus (QFT) tubes from experimentally M. bovis-infected and free-
ranging M. bovis uninfected white rhinoceros, were used for this study. Sample selection was 
based on a range of antigen-specific IFN-γ release assay (IGRA) responses. The Raybio® equine 
IP-10 ELISA kit was used for the detection of white rhinoceros IP-10. The IP-10 assay was able 
to distinguish between M. bovis-infected and uninfected white rhinoceros. Furthermore, using a 
preliminary calculated cut-off value, IPRA detected an additional truly infected animal with low 
IGRA response. These results indicate that white rhinoceros develop a measurable antigen-
specific IP-10 response, which can distinguish between M. bovis-infected and uninfected 
animals. Thus, the IP-10 assay shows moderate promise as a diagnostic biomarker and may 













The Kruger National Park (KNP), South Africa, is an endemic area for bovine 
tuberculosis (bTB), caused by infection with Mycobacterium bovis (M. bovis) (Renwick et al., 
2007). Mycobacterium bovis infection has been reported in a number of different wildlife 
species, including African rhinoceros (de Lisle et al., 2002; Hlokwe et al., 2014; Miller et al., 
2018). The white rhinoceros (Ceratotherium simum) is classified as “Near Threatened” by the 
International Union for Conservation of Nature and is under high poaching pressure in Africa 
(Emslie, 2012). Although white rhinoceros are susceptible to M. bovis infection, the extent of 
infection in exposed individuals or populations and its impact on conservation of this species are 
still unknown (Chileshe et al., 2019; Miller et al., 2018). Therefore, to understand M. bovis 
infection in white rhinoceros and prevent the spread of disease through translocation of infected 
animals, accurate diagnostic tests are necessary to screen individuals. 
Previous studies focused on bTB diagnosis in wildlife have shown the accuracy of blood-
based tests utilizing the QuantiFERON TB Gold Plus (QFT) system, which includes peptides 
simulating the M. bovis proteins 6 KDa early secretory antigenic target (ESAT-6) and the 10 kDa 
culture filtrate protein (CFP-10) (Bernitz et al., 2018; Roos et al., 2018). The basis of current 
blood-based assays is detection of cell-mediated immune (CMI) responses through the release of 
cytokines, such as interferon gamma (IFN-γ) (Parsons et al., 2011; Higgitt et al., 2019). Notably, 
antigen-specific IFN-γ responses in experimentally M. bovis-infected white rhinoceros were 
observed to peak 5 to 6 months post infection and gradually declined to low or undetectable 
levels within 12 to 20 months after infection (Parsons et al., 2017). However, these immune 
response patterns, together with limited bTB pathology and failure to isolate viable M. bovis 




controlled in white rhinoceros (Parsons et al., 2017). An IFN-γ release assay (IGRA) has been 
validated for use in white rhinoceros, findings suggested that rhinoceros with IGRA results 
should be interpreted as test negative (< 21 pg/ml), indeterminate (21–61 pg/ml), and test 
positive (> 61 pg/ml) (Chileshe et al., 2019).  Due to uncertainty associated with indeterminate 
results, repeat testing of these individuals is recommended, which is costly in terms of time, risk 
to animal, and expenses to immobilize and perform additional assays. Therefore, additional 
biomarkers of M. bovis infection in white rhinoceros may be useful to increase accuracy in 
interpreting results to diagnose bTB in this species, especially if the same sample could be used. 
In addition to IFN-γ, CXCL10/interferon gamma induced protein 10 (IP-10) has emerged 
as a potential biomarker for TB in humans (Ruhwald et al., 2007), cattle (Palmer et al., 2020), 
and wildlife (Goosen et al., 2015; Roos et al., 2018). Interestingly, findings from a recent study 
showed that an antigen-specific CXCL10 gene expression assay was able to distinguish between 
M. bovis-infected and uninfected white rhinoceros (Chileshe et al., manuscript submitted). 
Furthermore, in African buffalo (Syncerus caffer), the antigen-specific IP-10 release assay 
(IPRA) increased sensitivity (Se) when used in parallel with the IGRA for detection of M. bovis 
infection (Bernitz et al., 2018; Bernitz et al., 2019). Therefore, in the present study, archived 
QFT plasma samples from animals with a range of IGRA results were used to answer three 
questions: (i) can white rhinoceros IP-10 be detected in plasma from QFT-stimulated whole 
blood; (ii) can antigen-specific IPRA results differentiate between M. bovis-infected and 
uninfected white rhinoceros; and (iii) can antigen-specific IPRA results be used to increase 






Materials and Methods 
Sample selection 
Archived sample sets (n = 23) from 16 white rhinoceros were selected for this study. 
Each sample set had been stored at -80°C and included plasma harvested from whole blood 
incubated in the Nil, TB Antigen, and Mitogen tubes of the QFT system (Qiagen, Venlo, The 
Netherlands), as previously described (Chileshe et al., 2019). Initially, QFT Nil and QFT 
Mitogen plasma samples from three M. bovis uninfected animals were used to determine if there 
was detection of rhinoceros IP-10 using the selected ELISA. The remaining 20 sample sets were 
grouped into 4 categories based on the M. bovis infection status and IGRA responses of the 
individual animals, as determined in previous studies (Michel et al., 2017; Parsons et al., 2017; 
Chileshe et al., 2019). These included samples from uninfected animals with antigen-specific 
IGRA responses that were < 21 pg/ml (Group A, n = 5) or 21-61 pg/ml (Group B, n = 5), and M. 
bovis-infected animals with IGRA responses that were ≤ 61 pg/ml (Group C, n = 5) or > 61 
pg/ml (Group D, n = 5) (Table 5.1). Ethical approval for this project was granted by Stellenbosch 
University Animal Care and Use Committee (SU-ACU-2018-0966). 
Interferon gamma induced protein 10 (IP-10) release assay (IPRA) 
Due to the high homology between equine and rhinoceros CXCL10 mRNA sequences 
(Chileshe et al., manuscript submitted), the RayBio® equine IP-10 ELISA kit (RayBiotech Inc., 
Norcross, GA, USA) was selected as a candidate assay for detection of rhinoceros IP-10. As a 
pilot study, QFT Nil and QFT Mitogen plasma from three uninfected white rhinoceros were 
assayed in single ELISA wells. Hereafter, a serial dilution of equine recombinant IP-10 (rIP-10) 
(RayBiotech Inc.), a negative control consisting of kit dilution buffer, and all other samples were 




ELISA was performed according to the manufacturer’s instructions. The optical density (OD) of 
each well was measured at wavelengths of 450 nm (OD450) and 630 nm (OD630) using a 
VersaMax ELISA microplate reader with SoftMax Pro® software (Molecular Devices, San Jose, 
CA, USA). The sample OD was calculated as OD450–OD630 to account for light absorbance of 
the polystyrene plate. The OD result was calculated as the mean sample OD value for the 
duplicate samples minus the mean sample OD value of the background control.  
Data analysis 
White rhinoceros IP-10 OD results for the QFT Nil and QFT Mitogen-stimulated plasma 
from three M. bovis uninfected animals were compared using a one-tailed Mann-Whitney U-test 
(GraphPad Software, Inc., San Diego, CA, USA). Where applicable, the absolute concentration 
(pg/ml) of IP-10 for each sample was calculated from the mean OD results with reference to the 
standard curve (linear regression using GraphPad Software). The antigen-specific IP-10 release 
assay (IPRA) result for each rhinoceros was calculated as the concentration of IP-10 in the QFT 
TB Antigen tube minus the concentration of IP-10 in the QFT Nil tube measured in pg/ml. 
Negative values were assigned a value of 0 pg/ml. The median IPRA results were calculated 
along with interquartile range (IQR) and compared between M. bovis-infected and uninfected 
white rhinoceros cohorts using a one-tailed Mann-Whitney U-test (GraphPad Software). 
A preliminary diagnostic cut-off value for QFT IPRA was calculated using the formula 
mean + (2 x SD) using M. bovis uninfected animal samples and IPRA results were designated as 
either positive or negative based on this value. To determine if the IPRA sensitivity was similar 
for samples with low and high IGRA responses, the proportions of IPRA test-positive animals in 
groups C and D were compared using a Z test (GraphPad Software). A p value of 0.05 was used 





The plasma from QFT Nil and QFT Mitogen-stimulated whole blood of three M. bovis 
uninfected white rhinoceros showed a detectable IP-10 signal using the RayBio® equine IP-10 
ELISA kit (Fig. 5.1). Although IP-10 was detected in QFT Nil (unstimulated plasma) from all 
three animals, it was particularly high in one animal. Notably, OD values for plasma from QFT 
Mitogen-stimulated samples of all three animals were higher than those of the matched QFT Nil 
samples. However, there was no significant difference (p > 0.05) between median OD values of 
0.36 (range: 0.27–0.58) and 0.19 (range: 0.06–0.53) in the QFT Mitogen and QFT Nil samples, 
respectively. 
 
Figure 5.1 Optical density (OD) values of interferon gamma induced protein 10 (IP-10) in 
plasma harvested from QFT Nil and QFT Mitogen tubes (24 hours incubation at 37°C) from M. 
bovis uninfected white rhinoceros (n = 3), measured using the RayBio® equine IP-10 ELISA kit. 
Values of QFT Nil and QFT Mitogen samples were not statistically different (p = 0.20; one-
tailed Mann Whitney U-test). 
In order to determine if antigen-specific IP-10 could be detected, concentrations of IP-10 




samples from M. bovis-infected (n = 3 animals) and 10 uninfected rhinoceros were measured 
using the equine IP-10 ELISA. Concentrations of IP-10 in each sample and the IPRA results, 
along with previously determined IGRA results, are shown in Table 5.1.). The cut-off value of 
203 pg/ml was calculated and the distribution of QFT IPRA responses for M. bovis-infected and 
uninfected white rhinoceros is shown in Figure 5.2. Using this cut-off value IPRA results were 
categorized as test positive or negative (Table 5.1). Five out of 10 samples from the M. bovis-














Table 5.1 Test results of interferon gamma release assay and interferon gamma induced protein 10 release assay from Mycobacterium 
bovis experimentally infected (n=10 sample sets from three animal) and uninfected (n=10) free-ranging white rhinoceros. 
 




(pg/ml)  IP-10 (pg/ml)  IPRA 
     QFT Nil QFT TB  
Value 
(pg/ml) Outcome 
A M. bovis uninfected;  18/515 N/A 0 722 506  0 Neg
a 
 < 21 pg/ml IGRA response 18/630 N/A 0 68 81  13 Neg 
  19/70 N/A 0 1251 205  0 Neg
a 
  17/632 N/A 2 79 77  0 Neg
a 
  17/648 N/A 7 344 357  13 Neg 
B M. bovis uninfected;  19/306 N/A 22 699 724  25 Neg 
 21-61 pg/ml IGRA response 19/281 N/A 34 1374 1561  186 Neg 
  17/683 N/A 36 1640 1453  0 Neg
a 
  19/88 N/A 49 585 577  0 Neg
a 
  19/76 N/A 52 1407 1609  202 Neg 
C M. bovis infected;  PB4 1 14 169 880  711 Pos 
 ≤ 61 pg/ml IGRA response PB2 18 37 683 798  115 Neg 
  PB1 19 41 1207 962  0 Neg
a 
  PB4 18 48 449 436  0 Neg
a 
  PB2 16 52 7372 6355  0 Neg
a 
D  M. bovis infected; PB4 19 75 6148 6727  579 Pos 
 > 61 pg/ml IGRA response PB2 6 557 686 2066  1380 Pos 
  PB4 5 657 982 1123  141 Neg 
  PB2 3 731 5696 6872  1176 Pos 
  PB1 8 983 462 2373  1912 Pos 
M. bovis, Mycobacterium bovis; IGRA, Interferon gamma release assay; QFT, QuantiFERON TB Gold Plus tubes; IP-10, interferon gamma induced protein 10; 
IPRA, Interferon gamma induced protein 10 release assay; IPRA value, was calculated as the concentration of IP-10 in the QFT TB Antigen tube minus the 
concentration of IP-10 in the QFT Nil tube; Neg, negative; Pos, positive; N/A, not applicable, 







Figure 5.2 Antigen-specific interferon gamma-induced protein 10 (IP-10) production in samples 
from rhinoceros with known M. bovis infection status. Whole blood of M. bovis-infected (10 
sample sets from 3 experimentally infected individuals) and uninfected (n=10) white rhinoceros 
was stimulated for 24 hours using the QuantiFERON TB Gold Plus system. Cytokine production 
was measured in plasma supernatant using the RayBio® equine IP-10 ELISA kit (RayBiotech 











Rhinoceros QFT plasma samples were selected based on previously determined antigen-
specific IGRA results to determine if antigen-specific IPRA results could increase detection of 
M. bovis-infected individuals using the calculated cut-off value. In group A, all 5 uninfected 
animals with negative IGRA results (< 21 pg/ml) had negative IPRA results. Additionally, all 5 
uninfected rhinoceros with indeterminate IGRA results (21–61 pg/ml) in group B were also 
IPRA negative. Among the M. bovis-infected cohorts, one IGRA negative sample in group C 
(IGRA ≤ 61 pg/ml) was IPRA positive. Among group D, which had positive IGRA responses (> 
61 pg/ml), 4 out of 5 samples were IPRA positive. The proportions of IPRA positive results 
among the M. bovis-infected cohorts showed that group D was significantly higher than group C 
(p = 0.001). If the IGRA and IPRA results were used in parallel to determine M. bovis infection 
status, all the uninfected rhinoceros would be considered negative and one additional M. bovis 
infected animal would be test-positive. 
Discussion  
In this pilot study, white rhinoceros IP-10 release in whole blood was detected using the 
QFT stimulation platform and Raybio® equine IP-10 ELISA. In addition, this IPRA was able to 
detect an additional test-positive sample from a M. bovis-infected rhinoceros with a negative 
IGRA result. Therefore, IP-10 appears to be a promising biomarker to increase detection of truly 
infected white rhinoceros when used in parallel with IFN-γ.  
The Raybio® equine IP-10 ELISA could detect white rhinoceros IP-10 in plasma 
harvested from QFT stimulated whole blood. The high homology between white rhinoceros and 
equine cytokine sequences (Chileshe et al., manuscript submitted) predicted the anti-equine IP-
10 antibody cross-reactivity with the rhinoceros cytokine. Similarly, the use of commercially 




African buffaloes and common warthogs (Phacochoerus africanus), based on phylogenetic 
relationships (Goosen et al., 2014; Roos et al., 2018). Findings from this study indicate that the 
equine IP-10 ELISA kit may provide a readily available standardized method for cytokine 
detection in white rhinoceros.  
Notably, a wide range of IP-10 concentrations was detected in QFT Nil (unstimulated) 
plasma samples from both infected and uninfected white rhinoceros. This finding of spontaneous 
production of IP-10, in incubated whole blood from white rhinoceros, is similar to studies in 
cattle (Waters et al., 2012). Furthermore, similar to cattle, measurements of antigen-specific IP-
10 responses in rhinoceros were compromised by high levels of IP-10 in some unstimulated 
plasma samples (Parsons et al., 2016; Palmer et al., 2020). In addition, studies conducted in 
cattle (Palmer et al., 2020) and humans (Hong et al., 2014) have reported the measurements of 
IP-10 in serum samples, suggesting that in vivo induction of this cytokine contributed to the 
increased production. Furthermore, the secretion of IP-10 is enhanced by T cell secreted IFN-γ 
and numerous pro-inflammatory cytokines, such as IL-2, IFN-α, IFN-β, IL-27, IL-17, IL-23, 
TNF-α, and IL -1β which are secreted by antigen-presenting cells (Hong et al., 2014). 
Therefore, results from the present study highlight the potential confounding effect of 
high levels of IP-10 in QFT Nil (unstimulated) plasma samples from white rhinoceros. However, 
further investigation is necessary to determine if spontaneous IP-10 release will compromise the 
diagnostic performance of this assay in white rhinoceros.  
Antigen-specific IP-10 could differentiate between M. bovis-infected and uninfected 
white rhinoceros. Similarly, prior studies have demonstrated the use of IP-10 as a biomarker in 
the diagnosis of bTB in cattle (Parsons et al., 2016; Coad et al., 2019; Palmer et al., 2020), 




et al., 2018). Moreover, in the present study, a single QFT IGRA-negative sample from an M. 
bovis-infected rhinoceros tested IPRA positive. This sample was collected one month after 
experimental infection and may indicate the potential of the IPRA to detect early infection. This 
finding agrees with others showing that the parallel measurement of IFN-γ and IP-10 increased 
the detection of M. bovis-infected cattle and buffaloes (Parsons et al., 2016; Bernitz et al., 2019). 
However, the sensitivity of the IPRA was significantly greater for rhinoceros with positive IGRA 
results, reflecting the association between IFN-γ and IP-10 production. Nonetheless, our findings 
show the diagnostic potential of QFT IPRA for M. bovis infection in white rhinoceros with 
increased detection of truly infected animals when used in parallel with QFT IGRA. 
 Limitations of this pilot study prevent definitive conclusions on the diagnostic utility of 
IP-10 in white rhinoceros. The small sample size of M. bovis-infected and uninfected white 
rhinoceros may have influenced the calculation of appropriate IP-10 test cut-off values. Also, the 
inclusion of plasma samples from M. bovis experimentally infected, rather than naturally 
infected, white rhinoceros may not be a true reflection of host immune responses. In natural 
infections, rhinoceros are exposed to a number of environmental risk factors, such as drought, 
which could alter immune responses (Miller et al., 2017), and affect calculation of cut-off values. 
 In conclusion, while recent advancements have been made in the development of a QFT 
IGRA for the diagnosis of M. bovis infection in white rhinoceros, there remains a need for 
increased diagnostic sensitivity (Chileshe et al., 2019). This pilot study indicates that IP-10 has 
moderate promise as a diagnostic biomarker in this species and that its measurement in antigen-
stimulated whole blood may increase detection of truly infected animals. Future investigations 
should include recalculation of the diagnostic cut-off value with samples from larger cohorts of 




the observed spontaneous release of IP-10 in QFT-Nil samples is necessary to interpret IPRA 
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This chapter aims to synthesise all the results from the previous chapters and to contextualize the 






In 2016-2017, the first cases of M. bovis infection in a free-ranging black and white 
rhinoceros were discovered in KNP (Miller et al., 2017; Miller et al., 2018). Prior to finding 
naturally infected animals, a study to investigate susceptibility to M. bovis infection, progression 
to disease, and immune responses in white rhinoceros was performed by experimentally 
infecting three individuals (Michel et al., 2017; Parsons et al., 2017). This study demonstrated 
the potential utility of antigen-specific rhinoceros IGRAs for the detection of M. bovis in 
rhinoceros. However, even with findings from the experimentally and naturally infected 
rhinoceros, there were significant knowledge gaps regarding M. bovis transmission, diagnosis, 
and pathogenesis in these species.  
Understanding bTB in rhinoceros requires reliable and accurate tests to diagnose infected 
individuals and screen populations. Therefore, the studies presented in this PhD thesis aimed to 
identify and develop novel and optimized approaches for improving the detection of M. bovis 
infection in African rhinoceros. The thesis describes a novel IGRA for white rhinoceros that can 
distinguish between M. bovis-infected and uninfected individuals as well as pilot studies on the 
cytokine IP-10 release assay and CXCL10 (IP-10) gene expression assay. The results of these 
studies showed promise that IP-10 may be an additional cytokine biomarker for the detection of 
M. bovis in rhinoceros. 
Use of equine reagents for rhinoceros assays 
The use of commercially available equine reagents for rhinoceros diagnostic assays 
proved to be useful in this study. Although there is a recognized need to develop tests for 
infectious diseases and research to understand wildlife health, one of the major challenges is the 
lack of available reagents that can be used in wildlife diagnostic tests (Stallknecht, 2007). In 




important consequences for the quality and applications of an assay (Ryser-Degiorgis, 2013; 
Andersson et al., 2017). To develop indirect tests such as ELISAs, which are based on detecting 
the host immune response to a pathogen, one option is to develop rhinoceros-specific antibodies 
to cytokines, such as IFN-γ and IP-10, for the optimization of antigen-specific release assays. 
This has been done in a previous study where white rhinoceros IFN-γ was cloned, sequenced, 
and purified to produce a monoclonal antibody for the development of an IFN-γ ELISA (Morar 
et al., 2007). However, in the current study, commercially available antibodies and reagents were 
screened for cross-reactivity because the aim was to develop novel tests which would be easily 
accessible for use by other veterinary laboratories. Notably, cross-reactive binding was observed 
between anti-equine cytokine antibodies and rhinoceros cytokines, likely due to structurally 
similar epitopes of the equine and rhinoceros proteins because of the phylogenetic relationship 
between the species (Benjamin et al., 1984). Furthermore, results from our study demonstrated 
cross-reactivity of equine primers for rhinoceros transcripts, suggesting that these equine 
reagents could be used to develop qPCR assays to study immune responses in rhinoceros. 
Therefore, the approach of using commercially available reagents of closely related species 
provides a toolbox for assay development for rhinoceros and could be employed in other wildlife 
species to create new diagnostic tests.  
Validation of an IFN-γ ELISA  
In this study, the equine IFN-γ ELISA was validated for the diagnosis of M. bovis 
infection in white rhinoceros. Evaluation of an assay through various validation steps is 
important to ensure robustness and reproducibility (Andreasson et al., 2015). Notably, the IFN-γ 
ELISA tests previously used in rhinoceros for detecting cytokine responses have not been 




method that could be used to detect antigen-specific responses, not just to mycobacterial 
antigens, but could be modified to investigate IFN-γ responses to other antigens and provide a 
useful technique to study immunological responses in rhinoceros.  For example, various 
haemoparasites have been identified in African rhinoceros, particularly protozoan parasites 
including trypanosomes, Theileria bicornis, and Babesia bicornis, which have been shown to 
cause mortalities (Penzhorn et al., 1994; Nijof et al., 2003; Otiende et al., 2015; Yam et al., 
2018). Notably, previous studies have shown the role of IFN-γ in protective immunity to Babesia 
and Theileria infections in cattle (Ahmed, 2002). In addition, increased IFN-γ production was 
associated with resistance to African trypanosomes in experimentally infected mice (Hertz et al., 
1998). In another study, high levels of IFN-γ were involved in protection against acute babesiosis 
in infected mice (Aguilar-Delfin et al., 2002). Therefore, this validated ELISA could be used to 
investigate IFN-γ response in infection or vaccination of African rhinoceros to provide a basis of 
understanding the comparative immunology in these species.  
Diagnostic IGRA for rhinoceros 
In order to use a diagnostic test, it is essential to calculate a diagnostic cut-off value that 
results in acceptable performance and provides a level of statistical confidence for the purpose of 
the assay (Šimundić, 2009). In this study, the calculated diagnostic cut-off value for the QFT 
IGRA provided a method to distinguish between M. bovis-infected and uninfected white 
rhinoceros. In contrast, a previous study only used samples from uninfected rhinoceros to 
determine a diagnostic cut-off value (Morar et al., 2013). The use of ROC curve analysis in our 
study provided both an optimal cut-off value and as well as diagnostic accuracy of the test (Zou 
et al., 2007). Sensitivity and specificity are qualities of a diagnostic test which describe the 




understand the inverse relationship between sensitivity and specificity when setting the threshold 
for continuous data and that this may impact interpretation of results (Zou et al., 2007; Šimundić, 
2009).  Hence, a range of cut-off values was calculated in order to inform the optimal 
discriminative potential of the IGRA for rhinoceros. Additionally, to increase confidence and 
diagnostic accuracy, we sought to investigate other biomarkers for inclusion into a panel to 
diagnose M. bovis in African rhinoceros, similar to the approach used for human TB (Ruhwald et 
al., 2007; Chegou et al., 2018). 
Alternative biomarker discovery 
This study is the first to describe a potential alternative biomarker to IFN-γ for the 
diagnosis of M. bovis infection in white rhinoceros. An equine mRNA multiplex assay was used 
for the discovery of alternative cytokine/chemokine biomarkers that could potentially detect 
immunological changes in M. bovis-infected rhinoceros. This approach was selected since it 
allowed screening of multiple candidate target genes with minimal sample volume and a 
presumed likelihood of conserved cytokine gene sequences between equine and rhinoceros 
targets, compared to using a protein-based multiplex approach. Our results, along with previous 
studies in humans and animals, suggest that CXCL10/IP-10 can be used as an early diagnostic 
biomarker of TB (Whittaker et al., 2008; Roos et al., 2018; Bernitz et al., 2019; Palmer et al., 
2020). The current study also highlighted the potential improvement in detection of M. bovis-
infected rhinoceros using parallel measurements of IFN-γ and IP-10, which increases confidence 
in test result interpretation. High accuracy, sensitivity, and specificity of the tests are important 
because of the implications a positive test result has on the farm or park, which could include 
being put under quarantine. For this reason, identification and validation of a biomarker panel 




importance, particularly because early detection of infection is crucial to permit movement of 
rhinoceros locally, regionally and internationally, with confidence in their infection status. For 
example, if a rhinoceros from South Africa is imported into Australia, where bTB is eradicated 
(More et al., 2015), the risk of a false-negative test result could have widespread impacts on their 
agricultural trade status. In addition to determining current infection status, it will be important to 
follow infected rhinoceros over time to assess whether they can shed mycobacteria, eliminate, or 
contain infection, or progress to disease. Therefore, the development and validation of cytokine 
assays provide the first tools for studying the epidemiology and pathogenesis of bTB in African 
rhinoceros. 
Translational impact of study 
Translocation is a frequently applied approach in wildlife management, although this may 
be associated with risks of spreading disease (Daszak et al., 2000). Since the discovery of M. 
bovis-infected rhinoceros in KNP, the ability to translocate individuals, as a strategy to prevent 
loss due to poaching, has been curtailed due to the unknown risk of disease spread until an 
acceptable method of screening candidates could be developed. With the development of the 
QFT IGRA, the Department of Agriculture, Land Reform, and Rural Development, South 
Africa, has approved a rhinoceros TB management program using this assay to reduce this risk 
from animals translocated from KNP.  
Disease surveillance is important for understanding the impact and risks associated with a 
pathogen in a population. Wildlife disease surveillance is based on detection of infection using 
microbiological and immunological techniques (Artois et al., 2009; Ryser-Degiorgis et al., 
2013). In this study, the application of the QFT IGRA was used to assess M. bovis infection in 




13-25%), based on a positive test result (chapter 3). These initial results provide a foundation for 
evaluating the presence and impact of M. bovis infection in KNP and other rhinoceros 
populations. Furthermore, tools for surveillance and monitoring of M. bovis infections are not 
only essential for wildlife conservation but also to inform public health and agricultural disease 
management (Artois et al., 2009). Therefore, the development and validation of a blood-based 
IGRA, and potential for a diagnostic biomarker panel, for detection of M. bovis infection is an 
important advance for screening individual rhinoceros before movement between zoos or 
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This PhD thesis describes the development of novel diagnostic tools (IGRA, GEA and 
IPRA), which could identify and distinguish between M. bovis-infected and uninfected white 
rhinoceros. For the first time, we validated an IGRA, although its test performance had 
limitations in accurately interpreting results and the additional biomarker IP-10 was shown to 
have promise for increasing detection of M. bovis infection, suggesting that the use of both 
IGRA and IPRA in parallel improves diagnostic accuracy in rhinoceros. Therefore, the 
application of these tests to detect M. bovis infection by screening rhinoceros prior to 
translocation could prevent the spread of bTB and may contribute towards the control of the 
disease through surveillance and monitoring of their health. In addition, our study highlights a 
practical approach for the evaluation of CMI responses in white rhinoceros and identifies 
multiple candidate biomarkers worthy of further investigation for diagnosis of M. bovis infection 
in African rhinoceros. Furthermore, the findings create a platform for researchers to study the 
immunology of rhinoceros in the context of bTB and other conditions that may impact African 
rhinoceros species. 
Future studies 
To successfully advance this research, the diagnostic cut-off values of IGRA and IPRA 
should be further investigated in a larger population of African rhinoceros with known culture-
confirmed infection status. Additionally, samples from M. bovis uninfected rhinoceros 
populations should be included to determine if there are any factors influencing the performance 
of these diagnostic assays in animals from different locations. Additional studies should be 
conducted to assess the performance of parallel testing using the IPRA and IGRA in a large 
cohort with known infection status, which will confirm whether IPRA increases the detection of 




during early infection before IFN-γ becomes detectable and if high levels of IP-10 are indicative 
of disease in African rhinoceros. Since IP-10 appears to be produced spontaneously in 
unstimulated whole blood from both infected and uninfected rhinoceros, it will be important to 
investigate the mechanism behind its production and how this may cofound interpretation of 
assay results. Lastly, further studies should be performed to evaluate cytokines identified in this 
study as biomarker candidates for use in whole blood assays in addition to IFN-γ and IP-10, 
which would facilitate the development of a diagnostic panel for M. bovis detection in African 
rhinoceros. These studies would facilitate the understanding of immunology in the context of M. 




















Supplementary Table 1 
House Keeping genes (a) Qiagen RT2 Profiler PCR Array results for Housekeeping genes for QFT TB and QFT Nil samples obtained from 
rhinoceros R1. 
                        
HK Gene TB   Nil         
 Rep 1 (CT) Rep 2 (CT) Mean (CT) SD CV (%)   Rep 1 (CT) Rep 2 (CT) Mean (CT) SD CV (%) 
GAPDH 38.64 ud n.d. n.d. n.d.  43.73 ud n.d. n.d. n.d. 
ACTB 22.33 21.48 21.90 0.60 2.73  21.68 21.30 21.49 0.13 0.62 
B2M 18.56 17.99 18.28 0.40 2.22  17.60 16.28 16.94 0.47 2.76 
HPRT1 25.31 26.55 25.93 0.88 3.38  26.36 26.20 26.28 0.06 0.22 
LOC100056766 23.91 21.96 22.94 1.38 6.01  21.65 20.41 21.03 0.44 2.09 
HKV     22.26           21.43     
            
HK, Housekeeping            
TB, Sample obtained after 6 hour incubation of whole blood in the QuantiFERON TB Antigen 
Tube      
Nil, Sample obtained after 6 hour incubation of whole blood in the QuantiFERON Nil Tube       
Rep 1, Replicate 1            
Rep 2, Replicate 2            
CT, Reverse Transcription PCR Threshold Cycle          
SD, Standard Deviation           
CV, Coefficient of Variation            
ud, Undetermined            
n.d., Not Done            
HKV, Housekeeping value           






Valid QFT assay (b) Results for the Qiagen RT2 Profiler PCR Array and QFT Gene Expression Assay for rhinoceros R1. Results 
regarded as valid as replicate RT2 Profiler measurements have a CV < 10%.     
                    
Target 

























(CT)      
BMP2 39.80 34.28 37.04 3.90 10.53  34.81 35.72 35.27 0.64 1.83  22.26 21.43  14.78 13.83 0.94 0.52 
BMP6 32.21 27.81 30.01 3.11 10.38  32.39 26.73 29.56 4.00 13.54  22.26 21.43  7.75 8.13 -0.38 1.30 
CCL5 24.46 24.18 24.32 0.19 0.79  24.26 26.83 25.54 1.82 7.11  22.26 21.43  2.06 4.11 -2.05 4.15 
CCL8 31.54 29.98 30.76 1.10 3.58  31.78 32.62 32.20 0.59 1.83  22.26 21.43  8.50 10.77 -2.27 4.83 
CXCL10 41.44 35.63 38.53 4.11 10.67  42.31 38.91 40.61 2.41 5.93  22.26 21.43  16.27 19.18 -2.91 7.50 
GPI 31.68 27.06 29.37 3.27 11.12  27.42 26.86 27.14 0.40 1.47  22.26 21.43  7.11 5.71 1.40 0.38 
IL10 46.68 43.33 45.01 2.37 5.27  38.53 40.33 39.43 1.27 3.22  22.26 21.43  22.74 18.00 4.74 0.04 
IL1B 42.66 36.69 39.68 4.22 10.64  40.38 33.20 36.79 5.07 13.79  22.26 21.43  17.42 15.36 2.06 0.24 
IL23A 29.37 29.15 29.26 0.16 0.53  30.58 28.92 29.75 1.17 3.95  22.26 21.43  7.00 8.31 -1.31 2.49 
IL5 40.26 33.37 36.81 4.87 13.24  42.59 38.53 40.56 2.87 7.08  22.26 21.43  14.55 19.13 -4.58 23.89 
CXCL8 34.31 34.79 34.55 0.34 0.99  30.91 30.36 30.64 0.39 1.26  22.26 21.43  12.29 9.20 3.08 0.12 
CD40LG 27.70 26.72 27.21 0.69 2.55  23.10 27.45 25.27 3.07 12.17  22.26 21.43  4.95 3.84 1.11 0.46 
IL20 38.73 34.62 36.67 2.90 7.91  37.73 33.53 35.63 2.97 8.34  22.26 21.43  14.41 14.20 0.22 0.86 
IL24 32.77 31.44 32.10 0.94 2.94  29.86 30.12 29.99 0.18 0.60  22.26 21.43  9.84 8.56 1.28 0.41 
CCL4 18.25 18.32 18.29 0.05 0.26  19.57 18.80 19.18 0.55 2.85  22.26 21.43  -3.98 -2.25 -1.73 3.31 
LTA 29.47 27.54 28.51 1.37 4.79  29.94 29.88 29.91 0.04 0.14  22.26 21.43  6.24 8.48 -2.23 4.69 
LTB 27.99 27.74 27.87 0.18 0.65  28.41 27.48 27.94 0.65 2.34  22.26 21.43  5.60 6.51 -0.91 1.88 
NAMPT 23.38 21.99 22.68 0.99 4.34  21.01 20.68 20.84 0.24 1.15  22.26 21.43  0.42 -0.59 1.01 0.50 
TNFFSF11 33.51 29.51 31.51 2.83 8.98  29.13 28.39 28.76 0.52 1.80  22.26 21.43  9.25 7.33 1.92 0.26 
CXCL16 36.65 35.26 35.95 0.98 2.73  33.53 32.20 32.86 0.95 2.88  22.26 21.43  13.69 11.43 2.26 0.21 
IL32 37.94 36.22 37.08 1.22 3.28  35.07 37.69 36.38 1.85 5.09  22.26 21.43  14.81 14.95 -0.14 1.10 
CCL14 26.56 26.20 26.38 0.25 0.95  26.25 25.10 25.67 0.81 3.17  22.26 21.43  4.12 4.24 -0.12 1.09 
NODAL 30.00 27.90 28.95 1.48 5.12  30.18 30.16 30.17 0.01 0.05  22.26 21.43  6.69 8.74 -2.05 4.14 
CSF1 24.36 23.53 23.94 0.59 2.46  23.72 23.54 23.63 0.13 0.53  22.26 21.43  1.68 2.20 -0.52 1.43 




CCL20 41.25 34.36 37.81 4.87 12.89  32.62 35.98 34.30 2.37 6.92  22.26 21.43  15.55 12.87 2.68 0.16 
CXCL13 34.74 33.96 34.35 0.55 1.59  33.62 40.30 36.96 4.72 12.77  22.26 21.43  12.09 15.53 -3.44 10.85 
IL3 37.02 35.49 36.25 1.08 2.98  34.56 35.50 35.03 0.66 1.88  22.26 21.43  13.99 13.60 0.39 0.76 
TNF 26.54 24.86 25.70 1.18 4.61  26.78 25.62 26.20 0.82 3.12  22.26 21.43  3.43 4.77 -1.33 2.52 
TNFRSF11B 38.44 36.29 37.37 1.52 4.07  25.08 23.57 24.33 1.06 4.38  22.26 21.43  15.10 2.89 12.21 0.00 
TNFSF13B 31.72 27.79 29.76 2.78 9.34  23.77 23.27 23.52 0.36 1.51  22.26 21.43  7.50 2.08 5.41 0.02 
VEGFA 28.50 26.14 27.32 1.67 6.11   23.57 25.12 24.34 1.10 4.50   22.26 21.43   5.06 2.91 2.15 0.23 
                    
TB, Sample obtained after 6 hour incubation of whole blood in the 
QuantiFERON TB Antigen Tube             
Nil, Sample obtained after 6 hour incubation of whole blood in the 
QuantiFERON Nil Tube             
HKV, Housekeeping 
Value                   
CT, Reverse Transcription PCR Threshold 
Cycle                 
ΔCT (TB), Mean TB - HKV 
(TB)                   
ΔCT (Nil), Mean Nil - HKV 
(Nil)                  
ΔΔCT, ΔCT (TB) - 
ΔCT (Nil)                   
EFC, Expression Fold Change                  
Rep 1, Replicate 1                   
Rep 2, Replicate 2                   
SD, Standard 
Deviation                   
CV, Coefficient of Variation                   
ud, Undetermined                   










Invalid QFT assays (c) Results for the Qiagen RT2 Profiler PCR Array and QFT Gene Expression Assay for rhinoceros 
R1. Results regarded as invalid as RT2 Profiler replicates not available or CV < 10%.    
             
 Target Gene  QFT TB           QFT Nil         
  Rep 1 (CT) Rep 2 (CT) Mean SD CV (%)  Rep 1 (CT) Rep 2 (CT) mean SD CV (%) 
 BMP4 ud 42.64 n.d. n.d. n.d.  46.00 43.76 44.88 1.12 2.49 
 BMP7 7.97 ud n.d. n.d. n.d.  44.43 45.09 44.76 0.33 0.74 
 CCL11 ud ud n.d. n.d. n.d.  33.46 ud n.d n.d. n.d. 
 CCL13 ud ud n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 CCL2 38.47 43.73 41.10 2.63 6.40  39.97 ud n.d n.d. n.d. 
 CCL3 ud ud n.d. n.d. n.d.  13.71 ud n.d n.d. n.d. 
 CSF3 ud 37.83 n.d. n.d. n.d.  39.20 38.24 38.72 0.48 1.24 
 CXCL1 ud 7.76 n.d. n.d. n.d.  ud 47.55 n.d n.d. n.d. 
 CXCL2 17.85 36.89 27.37 9.52 34.79  36.25 36.24 36.24 0.00 0.01 
 CXCL6 34.86 14.93 24.89 9.97 40.05  42.93 ud n.d n.d. n.d. 
 CXCL9 26.90 40.31 33.61 6.71 19.95  48.14 38.34 43.24 4.90 11.33 
 FASLG 33.28 26.83 30.06 3.23 10.74  31.30 35.97 33.64 2.33 6.94 
 IFNG ud 43.28 n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 IL12A 34.16 33.77 33.96 0.19 0.57  40.57 ud n.d n.d. n.d. 
 IL12B 38.15 ud n.d. n.d. n.d.  36.35 21.84 29.10 7.25 24.93 
 IL13 47.75 ud n.d. n.d. n.d.  47.64 47.02 47.33 0.31 0.66 
 IL15 ud 43.65 n.d. n.d. n.d.  ud 36.30 n.d n.d. n.d. 
 IL16 12.77 46.33 29.55 16.78 56.79  45.26 43.15 44.21 1.05 2.38 
 IL17A 38.54 32.96 35.75 2.79 7.81  43.57 12.88 28.23 15.34 54.36 
 IL18 ud ud n.d. n.d. n.d.  31.64 ud n.d n.d. n.d. 
 IL1A 7.17 ud n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 IL1RN 34.48 ud n.d. n.d. n.d.  26.08 27.41 26.74 0.66 2.47 
 IL2 40.35 41.33 40.84 0.49 1.20  37.13 ud n.d n.d. n.d. 




 IL6 ud 35.63 n.d. n.d. n.d.  36.16 35.46 35.81 0.35 0.98 
 TGFB2 42.51 17.88 30.19 12.31 40.78  ud ud n.d n.d. n.d. 
 MIF 39.30 26.76 33.03 6.27 18.99  43.59 46.38 44.98 1.40 3.11 
 IL22 ud 33.54 n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 IL7 33.77 36.63 35.20 1.43 4.07  35.42 46.60 41.01 5.59 13.62 
 THPO 43.96 43.70 43.83 0.13 0.29  39.33 ud n.d n.d. n.d. 
 IL33 13.21 11.89 12.55 0.66 5.26  9.12 38.99 24.05 14.94 62.10 
 LOCI00060619 33.71 25.96 29.84 3.88 13.00  33.55 29.57 31.56 1.99 6.30 
 CCL24 ud ud n.d. n.d. n.d.  ud 47.59 n.d n.d. n.d. 
 CCL22 19.89 45.02 32.45 12.56 38.72  ud 36.58 n.d n.d. n.d. 
 IL9 46.93 ud n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 IL21 40.12 23.57 31.85 8.28 25.98  28.98 30.86 29.92 0.94 3.15 
 OSM ud ud n.d. n.d. n.d.  ud 48.03 n.d n.d. n.d. 
 TNFSF10 ud ud n.d. n.d. n.d.  ud 40.33 n.d n.d. n.d. 
 LOC100064468 45.38 ud n.d. n.d. n.d.  5.95 ud n.d n.d. n.d. 
 CD70 24.52 15.35 19.94 4.58 22.99  ud 40.58 n.d n.d. n.d. 
 IL32 37.94 36.22 37.08 0.86 2.32  35.07 37.69 36.38 1.31 3.60 
 CCL25 ud 45.79 n.d. n.d. n.d.  42.27 ud n.d n.d. n.d. 
 C5 11.11 44.18 27.64 16.54 59.82  45.60 7.63 26.61 18.98 71.32 
 IL17F ud 46.74 n.d. n.d. n.d.  36.38 40.24 38.31 1.93 5.04 
 CCL15 45.59 47.42 46.51 0.92 1.98  47.60 ud n.d n.d. n.d. 
 CCL16 44.73 ud n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 CCL28 ud ud n.d. n.d. n.d.  ud ud n.d n.d. n.d. 
 CNTF ud ud n.d. n.d. n.d.  ud 37.68 n.d n.d. n.d. 
 CXCL11 28.01 26.77 27.39 0.62 2.26  35.89 29.06 32.48 3.42 10.52 
 CCL26 45.64 ud n.d. n.d. n.d.  ud 42.11 n.d n.d. n.d. 
 CCL19 37.26 29.86 33.56 3.70 11.03  29.46 ud n.d n.d. n.d. 
 CCL17 46.57 ud n.d. n.d. n.d.  34.53 35.80 35.16 0.63 1.80 
 MSTN 6.91 42.06 24.49 17.58 71.79   33.37 48.68 41.03 7.66 18.67 
             




Nil, Sample obtained after 6 hour incubation of whole blood in the QuantiFERON Nil Tube     
HKV, Housekeeping Value           
CT, Reverse Transcription PCR Threshold Cycle         
Rep 1, Replicate 1            
Rep 2, Replicate 2            
SD, Standard Deviation            
CV, Coefficient of Variation            
ud, Undetermined            
n.d., Not Done            



















Supplementary Table 2 
House keeping genes (a) Qiagen RT2 Profiler PCR Array results for Housekeeping genes for samples obtained 
from rhinoceros R2.    
                         
   TB          Nil        
HK Gene Rep 1 (CT) Rep 2 (CT) Mean (CT) SD 
CV 
(%)  Rep 1 (CT) Rep 2 (CT) Mean (CT) SD CV (%)  
GAPDH 43.24 45.72 n.d. n.d. n.d  47.90 40.49 n.d n.d n.d  
ACTB 24.70 24.88 24.79 0.13 0.52  25.77 25.52 25.65 0.17 0.68  
B2M 19.86 19.63 19.75 0.16 0.79  19.57 19.75 19.66 0.13 0.65  
HPRT1 26.67 26.83 26.75 0.11 0.43  26.44 26.53 26.48 0.07 0.25  
LOC100056766 23.80 24.47 24.13 0.48 1.97  24.48 25.32 24.90 0.59 2.37  
HKV     23.85           24.17      
             
HK, Housekeeping            
TB, Sample obtained after 24 hour incubation of whole blood in the QuantiFERON 
TB Antigen Tube        
Nil, Sample obtained after 24 hour incubation of whole blood in the QuantiFERON 
Nil Tube        
Rep 1, Replicate 1            
Rep 2, Replicate 2            
CT, Reverse Transcription PCR Threshold Cycle           
SD, Standard Deviation            
CV, Coefficient of Variation             
ud, Undetermined            
n.d., Not Done             






Valid QFT assays (b) Results for the Qiagen RT2 Profiler PCR Array and QFT Gene Expression Assay for rhinoceros R2. Results regarded as 
valid as replicate RT2 Profiler measurements have a CV < 10%.    
                     
                     




(Nil) ΔΔCT EFT  


















(CT)       
BMP2 34.40 33.56 33.98 0.59 1.74  33.72 32.79 33.26 0.66 1.98  23.85 24.17  10.13 9.09 1.04 0.49  
BMP4 34.95 42.31 38.63 5.20 13.46  36.69 36.76 36.72 0.05 0.13  23.85 24.17  14.78 12.55 2.22 0.21  
BMP6 27.45 27.21 27.33 0.17 0.63  26.57 26.91 26.74 0.24 0.89  23.85 24.17  3.47 2.57 0.91 0.53  
CCL13 41.16 39.99 40.58 0.82 2.03  49.22 40.46 44.84 6.20 13.82  23.85 24.17  16.72 20.67 -3.95 15.44  
CCL5 27.01 26.92 26.96 0.06 0.24  27.35 27.72 27.54 0.26 0.96  23.85 24.17  3.11 3.37 -0.26 1.20  
CCL8 35.12 34.37 34.75 0.53 1.53  32.79 33.74 33.27 0.67 2.01  23.85 24.17  10.89 9.10 1.80 0.29  
CSF3 33.90 34.75 34.32 0.60 1.74  36.60 38.65 37.62 1.45 3.86  23.85 24.17  10.47 13.45 -2.98 7.91  
CXCL10 33.81 33.85 33.83 0.03 0.08  35.60 37.07 36.34 1.04 2.85  23.85 24.17  9.98 12.16 -2.19 4.56  
CXCL9 36.00 37.24 36.62 0.87 2.39  36.52 36.38 36.45 0.10 0.29  23.85 24.17  12.77 12.28 0.49 0.71  
GPI 27.68 28.45 28.06 0.55 1.96  29.59 30.60 30.09 0.72 2.38  23.85 24.17  4.21 5.92 -1.71 3.27  
IL10 41.79 36.32 39.05 3.87 9.90  42.77 38.26 40.52 3.19 7.87  23.85 24.17  15.20 16.35 -1.15 2.21  
IL12A 44.42 42.89 43.65 1.08 2.48  43.37 44.15 43.76 0.56 1.27  23.85 24.17  19.80 19.59 0.21 0.86  
IL17A 32.82 31.83 32.32 0.69 2.15  30.40 29.95 30.17 0.32 1.06  23.85 24.17  8.47 6.00 2.47 0.18  
IL1A 41.87 43.65 42.76 1.26 2.94  42.63 41.40 42.01 0.87 2.06  23.85 24.17  18.91 17.84 1.07 0.48  
IL1B 32.14 31.74 31.94 0.28 0.89  32.60 33.20 32.90 0.42 1.29  23.85 24.17  8.08 8.73 -0.65 1.57  
IL23A 28.12 28.38 28.25 0.18 0.65  27.19 27.76 27.47 0.40 1.46  23.85 24.17  4.40 3.30 1.10 0.47  
IL5 36.90 42.46 39.68 3.93 9.92  47.61 44.45 46.03 2.24 4.86  23.85 24.17  15.82 21.86 -6.04 65.58  
IL6 32.94 34.48 33.71 1.09 3.23  34.58 34.58 34.58 0.00 0.01  23.85 24.17  9.86 10.41 -0.55 1.47  
CXCL8 36.02 36.60 36.31 0.41 1.12  37.30 36.55 36.92 0.53 1.45  23.85 24.17  12.45 12.75 -0.30 1.23  
CD40LG 27.27 27.59 27.43 0.22 0.81  26.74 27.12 26.93 0.27 0.99  23.85 24.17  3.58 2.76 0.82 0.57  
IL20 33.29 33.01 33.15 0.20 0.59  32.24 32.32 32.28 0.06 0.18  23.85 24.17  9.30 8.11 1.19 0.44  
IL24 29.32 29.78 29.55 0.32 1.09  29.70 30.13 29.91 0.31 1.03  23.85 24.17  5.70 5.74 -0.05 1.03  
CCL4 25.64 25.77 25.71 0.09 0.35  28.52 28.00 28.26 0.37 1.31  23.85 24.17  1.85 4.09 -2.24 4.72  




IL22 28.77 28.94 28.85 0.12 0.42  28.32 28.77 28.55 0.32 1.12  23.85 24.17  5.00 4.37 0.62 0.65  
THPO 33.37 33.96 33.66 0.42 1.24  33.92 38.60 36.26 3.31 9.12  23.85 24.17  9.81 12.09 -2.28 4.86  
TNFFSF11 28.10 28.01 28.06 0.07 0.24  27.21 27.37 27.29 0.11 0.41  23.85 24.17  4.20 3.12 1.08 0.47  
CCL24 42.60 40.72 41.66 1.32 3.18  47.81 47.40 47.60 0.29 0.60  23.85 24.17  17.81 23.43 -5.63 49.41  
IL9 43.33 39.12 41.22 2.98 7.22  47.12 39.54 43.33 5.36 12.36  23.85 24.17  17.37 19.16 -1.79 3.45  
TNFSF10 46.96 49.89 48.42 2.08 4.29  48.49 47.14 47.82 0.95 1.99  23.85 24.17  24.57 23.64 0.93 0.53  
CD70 25.06 25.20 25.13 0.10 0.41  24.71 24.90 24.81 0.13 0.52  23.85 24.17  1.28 0.63 0.64 0.64  
IL32 27.77 27.48 27.62 0.21 0.75  26.77 26.83 26.80 0.04 0.15  23.85 24.17  3.77 2.63 1.14 0.45  
C5 25.98 25.99 25.98 0.01 0.02  26.62 27.24 26.93 0.44 1.62  23.85 24.17  2.13 2.76 -0.63 1.54  
IL17F 36.41 37.29 36.85 0.62 1.68  40.88 37.57 39.23 2.34 5.97  23.85 24.17  13.00 15.05 -2.06 4.16  
NODAL 31.71 32.25 31.98 0.38 1.19  30.76 31.96 31.36 0.85 2.71  23.85 24.17  8.13 7.19 0.94 0.52  
CCL16 30.90 31.79 31.34 0.63 2.00  31.55 33.26 32.40 1.21 3.73  23.85 24.17  7.49 8.23 -0.74 1.67  
CSF1 35.91 38.03 36.97 1.50 4.05  36.13 38.28 37.20 1.52 4.08  23.85 24.17  13.11 13.03 0.08 0.95  
LIF 41.23 40.48 40.85 0.53 1.30  40.92 37.67 39.30 2.30 5.84  23.85 24.17  17.00 15.13 1.87 0.27  
CNTF 26.47 26.82 26.64 0.25 0.93  25.78 25.88 25.83 0.07 0.26  23.85 24.17  2.79 1.66 1.13 0.46  
CXCL11 40.67 41.18 40.93 0.36 0.88  38.49 38.67 38.58 0.13 0.34  23.85 24.17  17.07 14.41 2.66 0.16  
CCL20 39.69 43.84 41.77 2.93 7.02  48.02 44.42 46.22 2.55 5.51  23.85 24.17  17.91 22.05 -4.13 17.54  
CXCL13 27.67 27.75 27.71 0.05 0.19  26.90 27.48 27.19 0.41 1.50  23.85 24.17  3.86 3.02 0.84 0.56  
IL3 35.91 38.67 37.29 1.95 5.22  37.87 36.01 36.94 1.31 3.55  23.85 24.17  13.43 12.77 0.66 0.63  
CCL26 29.29 29.77 29.53 0.34 1.16  29.61 31.01 30.31 0.99 3.27  23.85 24.17  5.67 6.14 -0.47 1.38  
CCL19 28.51 29.44 28.97 0.65 2.26  29.67 30.75 30.21 0.77 2.54  23.85 24.17  5.12 6.04 -0.92 1.89  
CCL17 24.70 24.88 24.79 0.13 0.52  25.77 25.52 25.65 0.17 0.68  23.85 24.17  0.93 1.48 -0.54 1.46  
MSTN 19.86 19.63 19.75 0.16 0.79  19.57 19.75 19.66 0.13 0.65  23.85 24.17  -4.11 -4.51 0.41 0.76  
TNF 43.24 45.72 44.48 1.75 3.94  47.90 40.49 44.19 5.24 11.85  23.85 24.17  20.63 20.02 0.60 0.66  
TNFRSF11B 26.67 26.83 26.75 0.11 0.43  26.44 26.53 26.48 0.07 0.25  23.85 24.17  2.90 2.31 0.59 0.67  
TNFSF13B 23.80 24.47 24.13 0.48 1.97  24.48 25.32 24.90 0.59 2.37  23.85 24.17  0.28 0.73 -0.45 1.37  
VEGFA 34.76 36.70 35.73 1.37 3.85   34.75 35.29 35.02 0.38 1.08   23.85 24.17   11.88 10.85 1.03 0.49  
                     
TB, Sample obtained after 6 hour incubation of whole blood in the QuantiFERON TB 
Antigen Tube             
Nil, Sample obtained after 6 hour incubation of whole blood in the QuantiFERON Nil 




HKV, Housekeeping Value                    
CT, Reverse Transcription PCR Threshold Cycle                  
ΔCT (TB), Mean TB - HKV (TB)                    
ΔCT (Nil), Mean Nil - HKV (Nil)                   
ΔΔCT, ΔCT (TB) - ΔCT (Nil)                    
EFC, Expression Fold Change               
Rep 1, Replicate 1                    
Rep 2, Replicate 2                    
SD, Standard Deviation                    
CV, Coefficient of Variation                     
ud, Undetermined                    
n.d., Not Done                     
                     
                     
                     
                     













Invalid QFT assays (c) Results for the Qiagen RT2 Profiler PCR Array and QFT Gene Expression Assay for rhinoceros R2. Results regarded as 
invalid as RT2 Profiler replicates not available or CV < 10%.    
                   
                   
Target Gene  QFT TB           QFT Nil                
 Rep 1 (CT) Rep 2 (CT) Mean SD CV (%)  Rep 1 (CT) Rep 2 (CT) mean SD CV (%)        
BMP7 ud ud n.d. n.d. n.d.  44.57 ud n.d. n.d. n.d.        
CCL11 ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
CCL2 43.63 ud n.d. n.d. n.d.  38.03 39.21 38.62 0.59 1.52        
CCL3 ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
CXCL1 ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
CXCL2 36.16 44.57 40.37 4.20 10.41  44.32 42.82 43.57 0.75 1.73        
CXCL6 25.17 ud n.d. n.d. n.d.  46.13 ud n.d. n.d. n.d.        
FASLG 42.40 37.27 39.84 2.57 6.44  35.64 45.85 40.74 5.11 12.53        
IFNG ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
IL12B 44.61 40.44 42.52 2.09 4.91  48.90 39.56 44.23 4.67 10.56        
IL13 44.21 45.96 45.08 0.87 1.94  ud 45.90 n.d. n.d. n.d.        
IL15 ud 49.99 n.d. n.d. n.d.  44.69 42.55 43.62 1.07 2.46        
IL16 46.54 ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
IL18 42.97 38.74 40.86 2.12 5.18  48.79 ud n.d. n.d. n.d.        
IL1RN 37.85 41.89 39.87 2.02 5.06  46.87 37.40 42.13 4.74 11.24        
IL2 ud 43.35 n.d. n.d. n.d.  ud 40.51 n.d. n.d. n.d.        
IL4 42.07 44.84 43.46 1.38 3.18  36.75 ud n.d. n.d. n.d.        
TGFB2 46.78 ud n.d. n.d. n.d.  ud 48.00 n.d. n.d. n.d.        
MIF 29.91 42.33 36.12 6.21 17.19  45.96 41.94 43.95 2.01 4.57        
LTA ud 49.74 n.d. n.d. n.d.  ud 41.44 n.d. n.d. n.d.        
IL7 41.65 40.96 41.30 0.35 0.84  ud ud n.d. n.d. n.d.        
NAMPT ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
IL33 45.90 48.20 47.05 1.15 2.45  ud ud n.d. n.d. n.d.        
LOCI00060619 ud ud n.d. n.d. n.d.  ud 48.00 n.d. n.d. n.d.        




CCL22 44.19 ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
IL21 ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
OSM 39.31 ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
LOC100064468 45.19 ud n.d. n.d. n.d.  ud 40.91 n.d. n.d. n.d.        
CCL25 49.26 ud n.d. n.d. n.d.  43.53 ud n.d. n.d. n.d.        
CCL15 ud ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
CCL14 49.10 ud n.d. n.d. n.d.  ud ud n.d. n.d. n.d.        
CCL28 ud 45.55 n.d. n.d. n.d.   49.27 ud n.d. n.d. n.d.        
                   
TB, Sample obtained after 24 hour incubation of whole blood in the QuantiFERON TB Antigen Tube           
Nil, Sample obtained after 24 hour incubation of whole blood in the QuantiFERON Nil Tube           
CT, Reverse Transcription PCR Threshold Cycle                
Rep 1, Replicate 1                  
Rep 2, Replicate 2                  
SD, Standard Deviation                  
CV, Coefficient of Variation                  
ud, Undetermined                  
n.d., Not Done                   
 
Stellenbosch University https://scholar.sun.ac.za
